Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer, June 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 452 articles: HTML format

Single Articles

1. JIANG R, Madondo M, Zhang X, Shao Y, et al
   Deep learning-based applicator selection between Syed and T&O in high-dose-rate brachytherapy for locally advanced cervical cancer: a retrospective study.
   Phys Med Biol. 2025 May 29. doi: 10.1088/1361-6560.
   PubMed    
   Abstract available
   
   

2. WEI J, Wang M, Wu Y
   Comprehensive analysis of mRNA and lncRNA expression for predicting lymph node metastasis in cervical cancer: a novel seven-gene signature approach.
   Front Genet. 2025;16:1524821.
   PubMed    
   Abstract available
   
   

3. TJOKROPRAWIRO BA, Novitasari K, Ulhaq RA
   Torsion Giant ovarian cysts in a postmenopausal woman with cervical cancer.
   Oxf Med Case Reports. 2025;2025:omaf054.
   PubMed    
   Abstract available
   
   

4. ZHANG M, Zhang Q, Wang X, Peng X, et al
   Prediction of clinical stages of cervical cancer via machine learning integrated with clinical features and ultrasound-based radiomics.
   Sci Rep. 2025;15:18862.
   PubMed    
   Abstract available
   
   

5. ABRAR SS, Isa SAM, Hairon SM, Ismail MP, et al
   Recent Advances in Applications of Machine Learning in Cervical Cancer Research: A Focus on Prediction Models.
   Obstet Gynecol Sci. 2025 May 29. doi: 10.5468/ogs.25041.
   PubMed    
   Abstract available
   
   

6. JING Q, Chen Q, Wang G, Wu T, et al
   LINC02593 impedes cell senescence via COP1-mediated p53 degradation in cervical cancer.
   Cell Signal. 2025 May 27:111907. doi: 10.1016/j.cellsig.2025.111907.
   PubMed    
   Abstract available
   
   

7. LEE KE, Kim JA, Kim MJ, Lee HN, et al
   Cervical adenocarcinoma misdiagnosed as a nabothian cyst during pregnancy: A case report and review of the literatures.
   Medicine (Baltimore). 2025;104:e42336.
   PubMed    
   Abstract available
   
   

8. GU Y, Guo H, Zhang J, Gao Y, et al
   MFFUNet: A hybrid model with cross-attention-guided multi-feature fusion for automated segmentation of organs at risk in cervical cancer brachytherapy.
   Comput Med Imaging Graph. 2025;124:102571.
   PubMed    
   Abstract available
   
   

9. XU X, Huang Y, Wei W, Lin Z, et al
   To explore the molecular mechanisms and shared genetic characteristics of rheumatoid arthritis and cervical cancer based on multiple omics and clinical samples.
   Discov Oncol. 2025;16:945.
   PubMed    
   Abstract available
   
   

10. ZHANG Z, Fu F, Zhuang S
    Mendelian randomization reveals limited causal effects of genetic variants on cervical cancer risk: insights from immune cell populations.
    Discov Oncol. 2025;16:944.
    PubMed    
    Abstract available
    
    

11. PALMIERI L, Zamuner FT, de Lima DG, Gosala K, et al
    CervicalMethDx: a precision DNA methylation test to identify risk of high-grade intraepithelial lesions in cervical cancer screening algorithms.
    Cancer Prev Res (Phila). 2025 May 29. doi: 10.1158/1940-6207.CAPR-25-0029.
    PubMed    
    Abstract available
    
    

12. GUPTA S, Dey A, Kundu S, Sinha Gupta S, et al
    Barriers to Cervical Cancer Screening in India: Insights from National Family Health Survey-5 Data.
    Asian Pac J Cancer Prev. 2025;26:1853-1861.
    PubMed    
    Abstract available
    
    

13. GANGWAR A, Raghuvanshi S, Bhalla S, Agarwal P, et al
    Quantification of Circulating HPV DNA as a Biomarker for Cervical pre-cancer and cancer: A Pilot Study.
    Asian Pac J Cancer Prev. 2025;26:1681-1687.
    PubMed    
    Abstract available
    
    

14. OGONCHO IM, Wakasiaka S, Mageto IG, Chege M, et al
    Effect of a Nurse-Led Educational Intervention on the Knowledge, Perceptions and Uptake of Cervical Cancer Screening among HIV-Infected Women in Kenya.
    Asian Pac J Cancer Prev. 2025;26:1591-1597.
    PubMed    
    Abstract available
    
    

15. LIAO H, Chang X, Hou X, Zhang F, et al
    Pancreatic metastasis from cervical cancer: A case report and literature review.
    Oncol Lett. 2025;30:349.
    PubMed    
    Abstract available
    
    

16. PENG H, Xu N, Gao D, Tan H, et al
    Fan beam computed tomography-guided online adaptive external radiotherapy for cervical cancer achieves pathological complete response: A case report.
    Oncol Lett. 2025;30:344.
    PubMed    
    Abstract available
    
    

17. YARDEN NT, Sport C, Bale C, Mukhopadhyay N, et al
    The Impact of Split Radiation Therapy on the Management of Locally Advanced Cervical Cancer in Central Virginia.
    Cureus. 2025;17:e83130.
    PubMed    
    Abstract available
    
    

18. YAO Y, Yang X, Fu Y, Zhang Y, et al
    Immunological features of various molecular subtypes of cervical cancer and their prognostic implications in the context of disulfidptosis.
    Front Oncol. 2025;15:1574911.
    PubMed    
    Abstract available
    
    

19. KURITA T, Yamamoto A, Hosoya T, Tsuchida M, et al
    Lack of knowledge, not vaccine hesitancy, is the main cause of low human papilloma virus vaccination rate among systemic lupus erythematosus patients in Japan after suspension of proactive recommendation: Analysis of a patients' survey.
    J Obstet Gynaecol Res. 2025;51:e16330.
    PubMed    
    Abstract available
    
    

20. XU S, Jiang T, Mao X, Cai L, et al
    Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study.
    BMC Womens Health. 2025;25:260.
    PubMed    
    Abstract available
    
    

21. TOYOSHIMA M, Takizawa A, Kubonoya K, Kurose K, et al
    The impact of medical expert-led sex education on sexual health knowledge among Japanese junior high school students: a quantitative study.
    BMC Public Health. 2025;25:1971.
    PubMed    
    Abstract available
    
    

22. DETLEFSEN SS, Andersen DS, Knudsen AO, Nottrup TJ, et al
    Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study.
    Support Care Cancer. 2025;33:509.
    PubMed    
    Abstract available
    
    

23. XIA P, Zhou J, Shen R, Wang D, et al
    Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomics.
    NPJ Precis Oncol. 2025;9:158.
    PubMed    
    Abstract available
    
    

24. CEA GARCIA J, Rodriguez Jimenez I, Rios-Pena L, Rubio Rodriguez MC, et al
    A risk nomogram for assessing complications in patients undergoing surgical procedures for cervical cancer. Does baseline quality of life play a role?
    J Obstet Gynaecol Res. 2025;51:e16318.
    PubMed    
    Abstract available
    
    

25. SUN C, Diao H, Zhang X, Han Z, et al
    Study on human papillomavirus (HPV) infection, typing, peripheral blood immune factor expression and vaginal microenvironment balance in cervical cancer screening population.
    Indian J Med Microbiol. 2025 May 26:100883. doi: 10.1016/j.ijmmb.2025.100883.
    PubMed    
    Abstract available
    
    

26. XIE H, Liu J, Sun L, Xie T, et al
    Study of the application of the deformed dose summation (DDS) method in brachytherapy for advanced cervical cancer and analysis of regional dosing in recurrent cervical cancer.
    Appl Radiat Isot. 2025;224:111945.
    PubMed    
    Abstract available
    
    

27. PANG C, Long X, Luo Y, Luo Y, et al
    Exploring program-cell death patterns to predict prognosis and sensitivity of cervical cancer immunotherapy via multi-omics analysis and clinical samples.
    Discov Oncol. 2025;16:940.
    PubMed    
    Abstract available
    
    

28. NAYAK S, Deo BS, Pal M, Panigrahi PK, et al
    Empirical Mode Decomposition and Grassmann Manifold-Based Cervical Cancer Detection.
    J Biophotonics. 2025 May 28:e202400584. doi: 10.1002/jbio.202400584.
    PubMed    
    Abstract available
    
    

29. GUO Y, Xiao Y, Zhang C, Wang Y, et al
    The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer.
    Front Cell Infect Microbiol. 2025;15:1574511.
    PubMed    
    Abstract available
    
    

30. KOUHEN F, El Ghanmi A, Inghaoun H, Miftah H, et al
    The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?
    Front Immunol. 2025;16:1573576.
    PubMed    
    Abstract available
    
    

31. HUANCA CHALLGUA C, Linander I, Goicolea I, Eid Rodriguez D, et al
    Geographical inequities in cervical cancer screening coverage in Bolivia: a spatial nationwide ecological study.
    Rev Panam Salud Publica. 2025;49:e44.
    PubMed    
    Abstract available
    
    

32. ZHOU Y, Liu J, Chen S, Pan W, et al
    Human Papillomavirus Genotyping and Viral Load as a Predictor of Cervical Lesions: A Prospective Study.
    J Med Virol. 2025;97:e70386.
    PubMed    
    Abstract available
    
    

33. CHEN Z, Li H, Zhao J, Feng H, et al
    Human Papillomavirus Genotype Distribution and Viral Load in Relation to Cervical Disease Severity: A Retrospective Study of Outpatient Data in Beijing, China.
    J Med Virol. 2025;97:e70409.
    PubMed    
    Abstract available
    
    

34. PAVELESCU LA, Mititelu-Zafiu NL, Mindru DE, Vladareanu R, et al
    Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications.
    Microorganisms. 2025;13:1000.
    PubMed    
    Abstract available
    
    

35. TOMAZIU-TODOSIA ANTON E, Anton GI, Scripcariu IS, Dumitrascu I, et al
    Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review.
    Int J Mol Sci. 2025;26:4961.
    PubMed    
    Abstract available
    
    

36. CHAI Y, Yu S, Lin G, Luo C, et al
    Polyphyllin I Inhibits the Metastasis of Cervical Cancer Through the Regulation of the beta-Catenin Signaling Pathway.
    Int J Mol Sci. 2025;26:4630.
    PubMed    
    Abstract available
    
    

37. MIRANDA CAN, Souza ATB, Soares AKMDC, Bernardes-Oliveira E, et al
    Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline Isolated from Erythrina velutina in SiHa Cervical Cancer Cell.
    Int J Mol Sci. 2025;26:4627.
    PubMed    
    Abstract available
    
    

38. ALI H, Rasool S, Saidu MB, German P, et al
    Characterization of the Antiproliferative and Antimetastatic Properties of Centrapalus pauciflorus Meroterpenoid Centrapalus Coumarin F.
    Int J Mol Sci. 2025;26:4489.
    PubMed    
    Abstract available
    
    

39. MANEA E, Anghel B, Stanescu AD, Rata AM, et al
    Adaptive Target Volume and Dosimetry in Image-Guided Radiotherapy for Cervical Cancer.
    J Clin Med. 2025;14:3418.
    PubMed    
    Abstract available
    
    

40. ADAMS J, Wingels A, Amir-Kabirian C, Jeschke JK, et al
    The Predictive Value of Preoperative Histological Risk Factors in Early Cervical Cancer.
    J Clin Med. 2025;14:3277.
    PubMed    
    Abstract available
    
    

41. KAZLAUSKAITE J, Zukiene G, Rudaitis V, Bartkeviciene D, et al
    The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia-A Review.
    Medicina (Kaunas). 2025;61:847.
    PubMed    
    Abstract available
    
    

42. ALZAKARI SA, Alhussan AA, Towfek SK, Metwally M, et al
    Cervical Cancer Detection Using Deep Neural Network and Hybrid Waterwheel Plant Optimization Algorithm.
    Bioengineering (Basel). 2025;12:478.
    PubMed    
    Abstract available
    
    

43. USSAI S, Seyidov T, Khomasuridze T, On Behalf Of The Regional Alliance Group Of Experts On Hpv Vaccination, et al
    Regional Alliance for Cervical Cancer Prevention in Eastern Europe and Central Asia: Progressing Towards the Target 1 of the Global Strategy for Cervical Cancer Elimination.
    Healthcare (Basel). 2025;13:1209.
    PubMed    
    Abstract available
    
    

44. TUNG HJ, Schwarzschild G, Gopep N, Yeh MC, et al
    Cervical Cancer Screening After Menopause.
    Healthcare (Basel). 2025;13:1157.
    PubMed    
    Abstract available
    
    

45. CHEPKORIR J, Perrin N, Kivuti-Bitok L, Gallo JJ, et al
    Barriers and Opportunities for HPV Self-Sampling in Underserved Rural Communities: Insights from a Mixed Methods Study.
    Int J Environ Res Public Health. 2025;22:783.
    PubMed    
    Abstract available
    
    

46. SMAIL L
    Quality of Life of Emirati Women with Cervical Cancer Using EORTC QLQ-30 and CX24: A First Look in the UAE.
    Int J Environ Res Public Health. 2025;22:671.
    PubMed    
    Abstract available
    
    

47. DING H, Jin H, Tang Y
    HPV genotype distribution and cervical lesions in Chongqing: a comprehensive analysis of 229,770 females (2015?2023).
    BMC Infect Dis. 2025;25:760.
    PubMed    
    Abstract available
    
    

48. MOUCHERAUD C, Chibaka S, Golub G, Kalande P, et al
    Factors associated with cervical cancer screening: results from cross-sectional surveys in Kenya and Malawi.
    BMC Public Health. 2025;25:1956.
    PubMed    
    Abstract available
    
    

49. KARIMI M, Parsania M, Motakef Kazemi N, Qomi M, et al
    Curcumin nanoemulsion suppresses HPV oncogenes and inhibits cervical cancer progression: in vitro and in vivo study.
    Virol J. 2025;22:165.
    PubMed    
    Abstract available
    
    

50. MALEKI A, Ahadinezhad B, Alizadeh A, Khosravizadeh O, et al
    Barriers and facilitators of pap-smear test uptake in Asia: a systematic review.
    BMC Public Health. 2025;25:1961.
    PubMed    
    Abstract available
    
    

51. ZHANG M, Sit JWH, Choi KC, Chow KM, et al
    Effects of a theory driven and culturally tailored educational program on promoting cervical cancer screening in rural populations.
    Sci Rep. 2025;15:18540.
    PubMed    
    Abstract available
    
    

52. MEHRA R, Ray A, Kumari A, Kaur A, et al
    Google Trends for the Human Papillomavirus Vaccine in India From 2010 to 2024: Infodemiological Study.
    J Med Internet Res. 2025;27:e69729.
    PubMed    
    Abstract available
    
    

53. ROSQVIST E, Niemela E, Liang S, Eriksson JE, et al
    Proliferation of Human Cervical Cancer Cells Responds to Surface Properties of Bicomponent Polymer Coatings.
    Nanomaterials (Basel). 2025;15:716.
    PubMed    
    Abstract available
    
    

54. SAAD A, Taylor A, Felder S, Helpman L, et al
    De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.
    Oncologist. 2025;30:oyaf096.
    PubMed    
    Abstract available
    
    

55. LI X, Zheng J, Zhang Z, Fu D, et al
    An investigation of HPV vaccination willingness and influential factors among college students in Beijing based on the BeSD framework and evaluation of momentary intervention effect.
    Hum Vaccin Immunother. 2025;21:2505354.
    PubMed    
    Abstract available
    
    

56. 
    Retraction notice: "MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer".
    Technol Cancer Res Treat. 2025;24:15330338251343588.
    PubMed    
    
    
    

57. SUNDAY UE, Stephanie MI, Otuonye F, Oluwadamilola D, et al
    Computational investigation of stigmasterol as a potential therapeutic agent for cervical cancer: insights from density functional theory (DFT) and molecular docking studies.
    In Silico Pharmacol. 2025;13:77.
    PubMed    
    Abstract available
    
    

58. NYAMBE A, Lubeya MK
    Editorial: Cervical cancer awareness - volume I: screening, vaccines, and prevention.
    Front Reprod Health. 2025;7:1579018.
    PubMed    
    
    
    

59. PATHAK P, Ghimire P, Chaudhary SK, Piya N, et al
    Awareness, Practice, and Barriers Regarding Cervical Cancer Screening Among Women of Kageshwori Manohara Municipality, Nepal.
    Obstet Gynecol Int. 2025;2025:5325540.
    PubMed    
    Abstract available
    
    

60. HE Z, Zheng X, Liu R, Zhao K, et al
    Recent Advances in HPV Detection: From Traditional Methods to Nanotechnology and the Application of Quantum Dots.
    Int J Nanomedicine. 2025;20:6333-6356.
    PubMed    
    Abstract available
    
    

61. SLADKOVA P, Brtnicky T, Hormandlova L, Polkova M, et al
    Occupational therapy in oncogynecology - a pilot study.
    Ceska Gynekol. 2025;90:113-121.
    PubMed    
    Abstract available
    
    

62. HESHAM W, Elzayat EM, Hosney M, Abo-Elghiet F, et al
    Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis.
    BMC Complement Med Ther. 2025;25:189.
    PubMed    
    Abstract available
    
    

63. ARAGE FG, Tadese ZB, Taye EA, Tsegaw TK, et al
    Cervical cancer screening uptake and its associated factor in Sub-Sharan Africa: a machine learning approach.
    BMC Med Inform Decis Mak. 2025;25:197.
    PubMed    
    Abstract available
    
    

64. APPIAH RS, Boakye K, Appiah G, Aidoo AA, et al
    Rural-urban variations in cervical cancer screening uptake among women in Ghana: Evidence from the 2022 Ghana Demographic and Health Survey.
    BMC Womens Health. 2025;25:255.
    PubMed    
    Abstract available
    
    

65. WEBER A, Voko Z, Kiss Z, Szatmari I, et al
    The impact of life tables on age standardized net survival of real-life example databases.
    BMC Med Res Methodol. 2025;25:145.
    PubMed    
    Abstract available
    
    

66. WANG Y, Yin Y, Wei Z, Zhou N, et al
    A retrospective study on the relationship between delirium and long-term cognitive function in elderly women following cervical cancer surgery.
    Medicine (Baltimore). 2025;104:e42120.
    PubMed    
    Abstract available
    
    

67. MCCLYMONT E, de Sanjose S, Garland SM, Moscicki AB, et al
    International Papillomavirus Society policy statement on human papillomavirus-based cervical cancer screening for women living with HIV.
    Prev Med. 2025;197:108314.
    PubMed    
    Abstract available
    
    

68. SHAO J, Zhang C, Tang Y, He A, et al
    Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer.
    PeerJ. 2025;13:e19422.
    PubMed    
    Abstract available
    
    

69. CAO G, Wei Y, Ma X
    Investigating Anti-Tumor Effects of Irisin in Cervical Cancer Cells: Cell Viability, Migration, and Tumor-Associated Macrophage Polarization.
    Discov Med. 2025;37:946-956.
    PubMed    
    Abstract available
    
    

70. GUO H, Wu H, Li J, Li R, et al
    Neurological and Cardiac Adverse Events in Cervical Cancer Treatment: A Case of Postoperative Sintilimab-Induced Encephalitis and Myocarditis.
    Am J Case Rep. 2025;26:e947730.
    PubMed    
    Abstract available
    
    

71. BAVOR C, Saunders T, Wolfe M, Smith MA, et al
    'I Don't Think There Is a One-Size-Fits-All': A Qualitative Study Exploring Healthcare Professional and Service Provider Perspectives of Using Innovative Models of Cervical Screening to Improve Equitable Access to Self-Collection.
    Cancer Med. 2025;14:e70981.
    PubMed    
    Abstract available
    
    

72. CHEN Q, Deng D, Zhu H, Li S, et al
    Integrative Analysis of Bulk Multiomics and Single-Cell Transcriptomics Elucidates Age-Related Molecular Landscape Alterations in Cervical Cancer.
    Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17464.
    PubMed    
    Abstract available
    
    

73. NTONIFOR MM, Tazinkeng NN, Kemah BL, Claudia NE, et al
    Factors associated with parental hesitancy towards the human papillomavirus vaccine: a cross-sectional study.
    Sci Rep. 2025;15:18284.
    PubMed    
    Abstract available
    
    

74. DU J, Tan T, Yu Y, Wang H, et al
    The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by Acinetobacter lwoffii through circ-LDHA/HMGB1.
    BMC Microbiol. 2025;25:326.
    PubMed    
    Abstract available
    
    

75. LEI Y, Chao M, Yang K, Gupta V, et al
    A novel network architecture for post-applicator placement CT auto-contouring in cervical cancer HDR brachytherapy.
    Med Phys. 2025 May 25. doi: 10.1002/mp.17908.
    PubMed    
    Abstract available
    
    

76. MINAKAWA T, Nozaki A, Nakajin T, Mitsube K, et al
    Concurrent chemoradiotherapy for advanced cervical cancer during second trimester pregnancy: A case report.
    J Obstet Gynaecol Res. 2025;51:e16326.
    PubMed    
    Abstract available
    
    

77. MA X, Xu Z, Wang X, Sun S, et al
    Aberrant WDR5 promotes the progression of cervical cancer through the YAP1- CTGF pathway.
    Life Sci. 2025;376:123712.
    PubMed    
    Abstract available
    
    

78. LE DC, Pham TM, Quy PN, Hamanishi J, et al
    Premature mortality due to cervical and ovarian cancers in Japan, 2000 to 2020.
    J Obstet Gynaecol Res. 2025;51:e16327.
    PubMed    
    Abstract available
    
    

79. PARVIZI M, Vaezi M, Jeddi F, Bakhshandeh M, et al
    The role and diagnostic value of deregulated miRNAs in cervical cancer.
    Discov Oncol. 2025;16:922.
    PubMed    
    Abstract available
    
    

80. DELIKTAS DEMIRCI A, Avci M, Kabukcuoglu K
    Fear of cancer levels of women who applied cervical cancer screening: a cross-sectional study of the effects of health beliefs related to cervical cancer and Pap-Smear test.
    Cancer Causes Control. 2025 May 25. doi: 10.1007/s10552-025-02008.
    PubMed    
    Abstract available
    
    

81. PEI K, Li D, Xi M
    Simple Hysterectomy as a Viable Alternative to Radical Hysterectomy for Early-Stage Cervical Cancer: A Population-Based Cohort Study.
    Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17520.
    PubMed    
    Abstract available
    
    

82. KENEALY BP, Lochner JE
    Cancer Screening in Women.
    Prim Care. 2025;52:233-248.
    PubMed    
    Abstract available
    
    

83. DORJI N, Dorji T, Dorjey Y, Tshering S, et al
    Bhutan achieves the 90-70-90 targets on the path to elimination of cervical cancer: Experience, challenges and way forward.
    J Cancer Policy. 2025;44:100596.
    PubMed    
    Abstract available
    
    

84. SHING JZ, Mashele S, Tsegaye AT, Da Costa Dias B, et al
    Changes in incidence of HPV-related cancers in South Africa (2011-21): a cross-sectional analysis of the South African National Cancer Registry.
    Lancet Glob Health. 2025;13:e1101-e1110.
    PubMed    
    Abstract available
    
    

85. MARCUS JZ, Nelson E, Linder M, Chelmow DP, et al
    ASCCP Clinical Consensus: Screening Recommendations for Clear Cell Adenocarcinomas in People Exposed to DES In Utero.
    J Low Genit Tract Dis. 2024;28:351-355.
    PubMed    
    Abstract available
    
    

86. MAHITI GR, Adam J, Luoga P
    Prevalence and determinants of cervical cancer screening among women aged 15-49 years in Tanzania: analysis of demographic and health survey 2022.
    Arch Public Health. 2025;83:135.
    PubMed    
    Abstract available
    
    

87. BOSE S, Das S, Maity S, Raychaudhuri D, et al
    Androgen receptor plays critical role in regulating cervical cancer cell migration.
    Mol Cell Endocrinol. 2025;606:112583.
    PubMed    
    Abstract available
    
    

88. GONG Y, Zhang W, Wang X, Zheng S, et al
    A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative homeostasis in cervical cancer.
    Cancer Lett. 2025;627:217815.
    PubMed    
    Abstract available
    
    

89. ANDRADE MO, Al-Alam OCM, Kim HJS, Batista JPT, et al
    Induction chemotherapy followed by chemoradiotherapy for locally advanced cervical cancer: A systematic review and meta-analysis.
    Cancer Treat Rev. 2025;138:102959.
    PubMed    
    Abstract available
    
    

90. PEZER NALETILIC M, Tomic K, Katic K, Gatalica Z, et al
    The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances.
    Biomol Biomed. 2025 May 22. doi: 10.17305/bb.2025.12597.
    PubMed    
    Abstract available
    
    

91. SCHERER-QUENZER AC, Findeis J, Herbert SL, Buchel J, et al
    Evaluating the necessity of endocone resection during LLETZ: Impact of routine ECC and follow-up testing in predicting persistent/recurrent cervical dysplasia.
    Women Health. 2025;65:442-452.
    PubMed    
    Abstract available
    
    

92. TU K, Luo Z, Yi L, Li Z, et al
    FoxM1 promotes the proliferation of cervical adenocarcinoma cells through transcriptional activation of FAM83D.
    Life Sci. 2025;374:123691.
    PubMed    
    Abstract available
    
    

93. BAI H, Wei X, Yan X, Wei S, et al
    GRHL3 specifically initiated by the TP63 transcription factor promotes the metastasis of squamous cell carcinogenesis.
    Cell Signal. 2025;132:111794.
    PubMed    
    Abstract available
    
    

94. HWANG JH, Kim B
    Postoperative Urinary Complications in Minimally Invasive Versus Abdominal Radical Hysterectomy: A Meta-Analysis With a Focus on Ureterovaginal Fistula.
    J Minim Invasive Gynecol. 2025;32:502-511.
    PubMed    
    Abstract available
    
    

95. MARLOW L, Drysdale H, Waller J
    Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection devices.
    J Med Screen. 2025;32:93-99.
    PubMed    
    Abstract available
    
    

96. CHAWLA N, Marshall J, Dubinskaya A, Wakefield D, et al
    Knowledge of the Human Papillomavirus Vaccine and Willingness to Accept Vaccination in the Postpartum Period.
    J Low Genit Tract Dis. 2024;28:340-344.
    PubMed    
    Abstract available
    
    

97. VIEIRA-BAPTISTA P, Costa M, Hippe J, Sousa C, et al
    Evaluation of Host Gene Methylation as a Triage Test for HPV-Positive Women-A Cohort Study.
    J Low Genit Tract Dis. 2024;28:326-331.
    PubMed    
    Abstract available
    
    

98. CAGNIN PEREIRA T, Cardoso LP, da Silva de Paiva W, Santos de Camargos L, et al
    Analysis of metabolic compounds and antitumorigenic effects of Albizia niopoides and Senegalia polyphylla leaves.
    Nat Prod Res. 2025;39:3140-3147.
    PubMed    
    Abstract available
    
    

99. CONZUELO RODRIGUEZ G, Cremer ML, Muwonge R, Basu P, et al
    Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials.
    JCO Glob Oncol. 2025;11:e2500050.
    PubMed    
    Abstract available
    
    

100. SAIDI SA, Jones MA
     RE: Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
     J Natl Cancer Inst. 2025 Jun 6:djaf130. doi: 10.1093.
     PubMed    
     
     
     

101. MONTEALEGRE JR, Hilsenbeck SG, Bulsara S, Parker SL, et al
     Self-Collection for Cervical Cancer Screening in a Safety-Net Setting: The PRESTIS Randomized Clinical Trial.
     JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2971.
     PubMed    
     Abstract available
     
     

102. RITTENBERG E, Richman IB, Corbie G, Gross CP, et al
     HPV Self-Collection for Cervical Cancer Screening-There's No Place Like Home.
     JAMA Intern Med. 2025 Jun 6. doi: 10.1001/jamainternmed.2025.2978.
     PubMed    
     
     
     

103. SACHIT BA, Dass SA, Rajan RS, Tye GJ, et al
     Development of an innovative approach for early diagnosis of cervical cancer using TCR?like antibodies targeting HPV18 E6 and E7 peptides.
     Mol Med Rep. 2025;32:218.
     PubMed    
     Abstract available
     
     

104. LIU S, Tan Z, Gong T, Tang X, et al
     Automatic cervical tumors segmentation in PET/MRI by parallel encoder U-net.
     Radiat Oncol. 2025;20:95.
     PubMed    
     Abstract available
     
     

105. MASON SA, Wang L, Alexander SE, Lalondrelle S, et al
     Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer.
     Phys Med Biol. 2025 Jun 5. doi: 10.1088/1361-6560.
     PubMed    
     Abstract available
     
     

106. HOUPERT R, Sylvestre E, Bouhnik AD, Ben-Diane MK, et al
     Burden of cervical cancer in Martinique, 2012-2021.
     Cancer Epidemiol. 2025;97:102857.
     PubMed    
     Abstract available
     
     

107. WANG Y, Liang Q, Liang S, Shan Y, et al
     Bardoxolone methyl blocks the efflux of Zn2+ by targeting hZnT1 to inhibit the proliferation and metastasis of cervical cancer.
     Protein Cell. 2025 Jun 5:pwaf044. doi: 10.1093.
     PubMed    
     
     
     

108. SRIRAM S, Jayakumar AD, Gollapalli PK, Chandrasekar S, et al
     Demand-side barriers and economic burden in accessing Human Papillomavirus screening for cervical cancer prevention in rural India: Evidence from a cross-sectional study.
     F1000Res. 2025;13:630.
     PubMed    
     Abstract available
     
     

109. MWANGI JH, Mtshali GN, Mbeje P
     Male partner roles in cervical cancer transmission and prevention in central Kenya: A quantitative approach.
     Health SA. 2025;30:2858.
     PubMed    
     Abstract available
     
     

110. MUGISHA NM, Pinder LF, Menon MP
     Editorial: Cervical screening awareness week 2023: integrating cervical cancer screening and precancer treatments.
     Front Oncol. 2025;15:1614832.
     PubMed    
     
     
     

111. LEITE E SILVA MH, Barbosa da Silva MA, Dos Santos DSR, Fagundes TC, et al
     PET for predicting chemoradiotherapy survival in cervical cancer: the search continues.
     Nucl Med Commun. 2025 Jun 5. doi: 10.1097/MNM.0000000000001999.
     PubMed    
     Abstract available
     
     

112. WALUYO ST, Yuseran H, Armanza F, Manalu FFEC, et al
     Emergency Radiation Therapy for Hemorrhage in Botryoides Sarcoma: A Pediatric Case Report.
     Am J Case Rep. 2025;26:e946434.
     PubMed    
     Abstract available
     
     

113. AO K, Yin M, Lyu X, Xiao Y, et al
     Corrigendum to "METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer" [Cancer Lett. 587 (2024) 216658].
     Cancer Lett. 2025 Jun 3:217827. doi: 10.1016/j.canlet.2025.217827.
     PubMed    
     
     
     

114. MORSEU-DIOP A, Butler T, Anderson K, Brotherton J, et al
     Stakeholder perspectives on HPV vaccination uptake among Aboriginal and Torres Strait Islander adolescents via the school immunisation programmes in Queensland: a qualitative study.
     BMJ Open. 2025;15:e097518.
     PubMed    
     Abstract available
     
     

115. FARAVEL K, Demontoy S, Jarlier M, De-Meric-de-Bellefon M, et al
     Impact of an educational physiotherapy-yoga intervention on perceived stress in women treated with brachytherapy for cervical cancer: a randomised controlled mixed study protocol (KYOCOL).
     BMJ Open. 2025;15:e098570.
     PubMed    
     Abstract available
     
     

116. UTEGENOVA A, Kassymova G, Fakhradiyev I
     EXPERIENCE OF IMPLEMENTING DIGITAL TELEMEDICINE TECHNOLOGIES TO IMPROVE ACCESS TO CERVICAL CANCER SCREENING IN RURAL AREAS OF THE REPUBLIC OF KAZAKHSTAN.
     Georgian Med News. 2025;:187-194.
     PubMed    
     Abstract available
     
     

117. HONG SW, Yoon KJ, Kang JH
     Interplay between human papillomavirus infection, cervical cancer history, and the incidence of oral cancer: A cohort study.
     Cancer Epidemiol. 2025;97:102858.
     PubMed    
     Abstract available
     
     

118. PANG G, Ruan X, Yao W, Cao M, et al
     Significance of PFKFB4 and gene risk signature in cervical cancer prognosis and progression.
     Biochem Biophys Res Commun. 2025;775:152084.
     PubMed    
     Abstract available
     
     

119. CORREA JUNIOR AJS, Santana ME, Araujo JS, Prates PEG, et al
     ChatGPT SMART Goals for collaborative practices in the Global Strategy to Accelerate the Elimination of Cervical Cancer.
     Cien Saude Colet. 2025;30:e00662025.
     PubMed    
     Abstract available
     
     

120. DING W, Liu S, Zhang H, Ding H, et al
     Identification and validation of a thirteen-gene signature based on ubiquitin related genes in cervical cancer.
     Discov Oncol. 2025;16:1000.
     PubMed    
     Abstract available
     
     

121. LI X, Cheng Y, Ji M, Liu J, et al
     Single-cell RNA sequencing analysis reveals a lack of CXCL13(+) T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy.
     Cancer Immunol Immunother. 2025;74:235.
     PubMed    
     Abstract available
     
     

122. MISHRA V, Bisht S, Chaudhary S, Pandey L, et al
     Comparative Evaluation of Dosimetric Parameters in Carcinoma Cervix Patients Undergoing Intensity-Modulated Radiotherapy versus Three-Dimensional Radiotherapy: A Retrospective Analysis.
     Gulf J Oncolog. 2025;1:7-12.
     PubMed    
     Abstract available
     
     

123. ZHANG D, Fu R, Sun G, Yan J, et al
     Comprehensive Pan-cancer Analysis and Experimental Verification of EGLN Family: Potential Biomarkers in Cervical Cancer.
     Curr Cancer Drug Targets. 2025 Jun 3. doi: 10.2174/0115680096362252250527060004.
     PubMed    
     Abstract available
     
     

124. SUN C, Zhang J, Pan L, Yao S, et al
     Innovative nomogram for cervical cancer prediction: integrating high-risk HPV infection, p53 genotype, and blood routine parameters.
     Front Oncol. 2025;15:1541928.
     PubMed    
     Abstract available
     
     

125. ALSHAHRANI MN, Almutairi D, Zahrani Y, Alsabaani A, et al
     Barriers associated with the parental acceptance of human papillomavirus (HPV) vaccination of minors in Asir, Saudi Arabia: A cross-sectional study.
     Hum Vaccin Immunother. 2025;21:2513708.
     PubMed    
     Abstract available
     
     

126. OZEN S, Demircivi E, Turgut A, Sanci M, et al
     Evaluation of lymph node metastasis in cervical cancer: A retrospective comparison of preoperative MRI and PET/CT with postoperative histopathology results.
     Turk J Obstet Gynecol. 2025;22:129-133.
     PubMed    
     Abstract available
     
     

127. CIM N, Ayguler E, Gunal N, Cim B, et al
     Systemic Inflammatory Response Index in Cervical Pathologies (Human Papillomavirus and Cervical Neoplasia) and its Prognostic Value in Disease Prediction.
     Niger J Clin Pract. 2025;28:615-623.
     PubMed    
     Abstract available
     
     

128. JIANG L, Wu T, Qu X, Li S, et al
     Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer.
     J Nanobiotechnology. 2025;23:413.
     PubMed    
     Abstract available
     
     

129. SILVA NNT, Santos ACS, Pereira IOA, da Silva GN, et al
     Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer.
     Mol Diagn Ther. 2025 Jun 3. doi: 10.1007/s40291-025-00790.
     PubMed    
     Abstract available
     
     

130. LEE J, Baek IW, Lim H, Chung MK, et al
     Risk for Human Papillomavirus-Associated Gynecologic Cancers Among Women of Childbearing Age With Rheumatic Diseases: A Population-Based Cohort Study.
     J Korean Med Sci. 2025;40:e95.
     PubMed    
     Abstract available
     
     

131. DA SILVA JL, de Miranda AVSS, Arruda GV, de Andrade DAP, et al
     Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Cervical Cancer (SCORE): a Systematic Review and Meta-analysis.
     Crit Rev Oncol Hematol. 2025 Jun 1:104789. doi: 10.1016/j.critrevonc.2025.104789
     PubMed    
     Abstract available
     
     

132. JAISWAL S, Mishra V, Majumder S, Wangikar PP, et al
     Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression.
     Biochim Biophys Acta Mol Cell Res. 2025;1872:119994.
     PubMed    
     Abstract available
     
     

133. DA FONSECA DO, Puga MAM, Gubert VT, Pereira EFV, et al
     Cellular Immune Response to High-Risk Human Papillomavirus Infection: A Systematic Review.
     Crit Rev Immunol. 2025;45:33-49.
     PubMed    
     Abstract available
     
     

134. ZENG S, Li X, Xiao S, Yang P, et al
     The efficacy and safety of Tisotumab vedotin in the treatment of recurrent/metastatic cervical cancer: a systematic review and meta-analysis of single-arm studies.
     Front Pharmacol. 2025;16:1538980.
     PubMed    
     Abstract available
     
     

135. HUANG B, Zheng J, Chen B, Wu M, et al
     Analysis of the correlation between RFC4 expression and tumor immune microenvironment and prognosis in patients with cervical cancer.
     Front Genet. 2025;16:1514383.
     PubMed    
     Abstract available
     
     

136. ZHANG W, Liu YM, Li D, Liu S, et al
     Research progress on tumor-infiltrating lymphocyte therapy for cervical cancer.
     Front Immunol. 2025;16:1524842.
     PubMed    
     Abstract available
     
     

137. ZHANG Y, Zhu J, Hu K, Qiu J, et al
     Multi-omics analyses construct an inflammatory response based prognostic gene signature for cervical cancer and suggest tumor infiltrating monocytes subgroups as key players.
     Front Immunol. 2025;16:1563593.
     PubMed    
     Abstract available
     
     

138. MURUGAN R
     Insights on the prognostic value of visceral obesity in stage IVB cervical cancer treatment.
     Cancer Pathog Ther. 2025;3:267-268.
     PubMed    
     
     
     

139. JEYARAJ G
     Commentary on the "Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy".
     Cancer Pathog Ther. 2025;3:269-270.
     PubMed    
     
     
     

140. KONG F, Yan Z, Gao L, Long J, et al
     Study on the relationship between vaginal dose and radiation-induced vaginal injury following cervical cancer radiotherapy, and model development.
     Front Public Health. 2025;13:1585481.
     PubMed    
     Abstract available
     
     

141. SHRESTHA A, Poudel L, Khanal B, Poudel K, et al
     Community-based Screening of Cervical Cancer in an Urban Setting in Nepal: A Cross-sectional Study.
     Kathmandu Univ Med J (KUMJ). 2024;22:413-418.
     PubMed    
     Abstract available
     
     

142. DHAKAL M, Basel P
     Prevalence of Depression and Associated Factors among Cervical Cancer Patients Attending Tertiary Center in Bhaktapur, Nepal.
     Kathmandu Univ Med J (KUMJ). 2024;22:385-392.
     PubMed    
     Abstract available
     
     

143. 
     Deregulation of LIMD1-VHL-HIF-1alpha-VEGF pathway is associated with different stages of cervical cancer.
     Biochem J. 2025;482:BCJ20170649.
     PubMed    
     
     
     

144. TRANBERG M, Van Keer S, Jensen JS, Norgaard P, et al
     High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality-a Danish diagnostic test accuracy study.
     BMC Med. 2025;23:327.
     PubMed    
     Abstract available
     
     

145. SATHIYASEELAN G, Hashim SM, Nawi AM
     Sociocultural factors influencing women's adherence to colorectal, breast, and cervical cancer screening: a systematic review.
     BMC Public Health. 2025;25:2034.
     PubMed    
     Abstract available
     
     

146. WANG Y, Wang D, Chen H, Zhang Y, et al
     High HPV viral load predicts worse prognosis in patients with cervical cancer treated with radiochemotherapy.
     Int J Radiat Biol. 2025 Jun 2:1-14. doi: 10.1080/09553002.2025.2510668.
     PubMed    
     Abstract available
     
     

147. GINN M, Stahlman SL, Fan MT, Baker Miller S, et al
     Trends in cervical cancer screening modality in the active component U.S. military, 2013-2023.
     MSMR. 2025;32:14-18.
     PubMed    
     Abstract available
     
     

148. SUN C, Meng X, Cui X, Liang S, et al
     APG-115 synergizes with bortezomib to induce apoptosis in cervical cancer cells.
     Anticancer Drugs. 2025 Jun 3. doi: 10.1097/CAD.0000000000001735.
     PubMed    
     Abstract available
     
     

149. KAZEMI S, Zarei F, Hidarnia A, Alhani F, et al
     Efficacy of digital educational intervention using I-Change model in promoting preventive behaviors for cervical cancer among Iranian women: A randomized controlled trial.
     Health Promot Perspect. 2025;15:44-53.
     PubMed    
     Abstract available
     
     

150. NIKFAR S, Mousavi AS, Akhavan S, Sheikhhasani S, et al
     Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in women with stage IB-IIB cervical cancer: Do we need to change the therapeutic approach? A cohort study.
     Surg Pract Sci. 2025;21:100284.
     PubMed    
     Abstract available
     
     

151. ZHANG R, Chai S, Chen Q, Lai J, et al
     The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation.
     Int J Womens Health. 2025;17:1511-1532.
     PubMed    
     Abstract available
     
     

152. OKU Y, Itou S, Wakamatsu S, Niiyama Y, et al
     Investigation of Dosimetric Evaluation and Treatment Planning Time of Inverse Planning Optimization in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
     Cureus. 2025;17:e83330.
     PubMed    
     Abstract available
     
     

153. ZHANG W, Ge Y, Yao L, Yan Q, et al
     Changes of Microbiome in Human Papillomavirus Infection and Cervical Cancer: A Systematic Review and Meta-Analysis.
     Cancer Rep (Hoboken). 2025;8:e70246.
     PubMed    
     Abstract available
     
     

154. CHEN S, Du Q, Yin J, Xu X, et al
     HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination.
     Virol J. 2025;22:176.
     PubMed    
     Abstract available
     
     

155. PATEL PG, Chowdhury S, Wiener HW, George JT, et al
     Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama.
     J Community Health. 2025 Jun 1. doi: 10.1007/s10900-025-01482.
     PubMed    
     Abstract available
     
     

156. QIU J, Xu J, Zhang J, He H, et al
     Exploring the mechanism by which BXSD decoction treats cervical cancer through the combination of network pharmacology and molecular docking analysis: Molecular mechanism of AKT1 and CASP3 protein.
     Int J Biol Macromol. 2025;317.
     PubMed    
     Abstract available
     
     

157. YANG Z, Liu Z, Ablise M, Jia J, et al
     Design, synthesis, and in vitro and in vivo anti-drug resistant cervical cancer activity of novel licochalcone A derivatives based on dual targeting of VEGFR-2/P-gp.
     Bioorg Chem. 2025;163:108639.
     PubMed    
     Abstract available
     
     

158. CHEN Q, Deng D, Zhu H, Li S, et al
     ASO Author Reflections: Multi-omic and Single-Cell Insights into the Age-Related Molecular Landscape of Cervical Cancer.
     Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17543.
     PubMed    
     
     
     

159. FAILLACE THIESEN J, Jacquemet E, Campagne P, Chatelain D, et al
     Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay.
     Mol Med. 2025;31:215.
     PubMed    
     Abstract available
     
     

160. CHINO J, Erickson B, Gaffney D, Hsu IC, et al
     The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer.
     Brachytherapy. 2025 May 29:S1538-4721(25)00086.
     PubMed    
     Abstract available
     
     

161. CULLIMORE V, Newhouse R, Baker-Rand H, Brentnall AR, et al
     Postnatal instead of normally-timed cervical screening (PINCS-1): a protocol for a feasibility study of paired-sample cervical screening and urine self-sampling at 6 weeks and 12 weeks postnatal in the UK.
     BMJ Open. 2025;15:e092701.
     PubMed    
     Abstract available
     
     

162. LI L, Zhao Y, Li X, Tian M, et al
     Osthole inhibits proliferation and induces autophagy-dependent ferroptosis of cervical cancer cells through induction of TFR1.
     Food Chem Toxicol. 2025;203:115577.
     PubMed    
     Abstract available
     
     

163. CLARK CR, Lykken JM, Chen PM, Haas JS, et al
     Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management Guidelines.
     J Gen Intern Med. 2025 May 30. doi: 10.1007/s11606-025-09611.
     PubMed    
     Abstract available
     
     

164. MOHAMED Y, Luey E, Kata ', Tukia O, et al
     "The only vaccine that we really question is the new vaccine": A qualitative exploration of the social and behavioural drivers of human papillomavirus (HPV) vaccination in Tonga.
     Vaccine. 2025;59:127280.
     PubMed    
     Abstract available
     
     

165. SOARES LMC, de Medonca AEO, de Souza DLB, Carvalho AV, et al
     Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study.
     Vaccine. 2025;59:127278.
     PubMed    
     Abstract available
     
     

166. MULCAHY SYMMONS S, Drury A, De Brun A
     Understanding the Influences of Cervical Screening Attendance among Women of Low Socioeconomic Position Using the Integrated Screening Action Model: A Qualitative Study.
     Semin Oncol Nurs. 2025;41:151891.
     PubMed    
     Abstract available
     
     

167. PU X, Wang X, Wang J, Gu Z, et al
     Microbial and metabolic profiles associated with HPV infection and cervical intraepithelial neoplasia: a multi-omics study.
     Microbiol Spectr. 2025;13:e0019225.
     PubMed    
     Abstract available
     
     

168. HE D, Lv Q, Li B, Xu M, et al
     Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in cervical precancerous lesions.
     Cancer Genet. 2025;294-295:99-110.
     PubMed    
     Abstract available
     
     

169. XU T, Zhang Y, Li S, Dai C, et al
     Deep Learning-Enhanced Hand-Driven Microfluidic Chip for Multiplexed Nucleic Acid Detection Based on RPA/CRISPR.
     Adv Sci (Weinh). 2025;12:e2414918.
     PubMed    
     Abstract available
     
     

170. MBABAZI E, Munyemana JB, Mukashema J, Bazimaziki E, et al
     Prevalence of Human Papillomavirus and Genotype Correlation with Cervical Lesions at the University Teaching Hospital of Kigali.
     Am J Trop Med Hyg. 2025;112:1335-1340.
     PubMed    
     Abstract available
     
     

171. OHYA A, Fukuzawa T, Himoto Y, Kido A, et al
     Age-related changes in the radiologic findings of lobular endocervical glandular hyperplasia: a multicenter study.
     Jpn J Radiol. 2025;43:985-994.
     PubMed    
     Abstract available
     
     

172. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
     Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
     J Surg Oncol. 2025;131:1110-1117.
     PubMed    
     Abstract available
     
     

173. BOOSFELD L, Lang S, Mattheis S, Peis M, et al
     [Diagnosis, treatment and oncological outcome of cervical CUP-syndrome depending on p16 status].
     Laryngorhinootologie. 2025;104:361-370.
     PubMed    
     Abstract available
     
     

174. WANG S, Huang X, Zhou X, Chen L, et al
     Endocervical Adenocarcinoma With Micropapillary Component, a Distinct Histological Subtype Associated With Aggressive Behavior and Poor Prognosis: A Clinicopathologic Study of 10 Patients.
     Int J Surg Pathol. 2025;33:801-808.
     PubMed    
     Abstract available
     
     

175. KOSAKA T, Takaori K, Izumiya A, Hirai D, et al
     Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with Predominantly Lymphocyte and Plasma Cell Infiltration.
     Intern Med. 2025;64:1696-1705.
     PubMed    
     Abstract available
     
     

176. VAN DE SANDE AJM, van Baars R, Koeneman MM, Gerestein CG, et al
     Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.
     BJOG. 2025;132:1056-1064.
     PubMed    
     Abstract available
     
     

177. BALKRISHNA A, Sharma Y, Dabas S, Arya V, et al
     Multifaceted computational insights of murrayacinine as dual inhibitors of CDK2 and MAPK3 to combat cervical cancer.
     Biochem Biophys Res Commun. 2025;775:152178.
     PubMed    
     Abstract available
     
     

178. SEWERYN M, Banas T, Leszczynska A, Augustynska J, et al
     Assessing the economic burden of cervical cancer in Poland: the critical role of productivity loss.
     Med Pr. 2025 Jun 10:204342. doi: 10.13075/mp.5893.01601.
     PubMed    
     Abstract available
     
     

179. ZHOU X, Bao R, Guan X, Li W, et al
     A pay-it-forward approach to improve feedback rate of HPV-based self-sampling in cervical cancer screening among women in ethnic minority regions of China: a randomized controlled trial protocol.
     Front Psychiatry. 2025;16:1586076.
     PubMed    
     Abstract available
     
     

180. LI Y, Wang Y, Liu X, Xue H, et al
     Integrative Analysis of Shared Pathogenic Genes and Potential Mechanisms in Gardnerella vaginalis and Persistent HPV16 Infection.
     Mediators Inflamm. 2025;2025:2582989.
     PubMed    
     Abstract available
     
     

181. GAO J, Yin W, Zhang Z, Zhou Q, et al
     Association between examined lymph node count and survival in resectable cervical cancer: a retrospective analysis using SEER data.
     Front Oncol. 2025;15:1553587.
     PubMed    
     Abstract available
     
     

182. MUNNE K, Patil P, Mayekar A, Birje S, et al
     Determinants of cervical cancer screening acceptance among women in urban and tribal communities of Maharashtra, India: a cross-sectional study.
     Cancer Prev Res (Phila). 2025 Jun 13. doi: 10.1158/1940-6207.CAPR-25-0174.
     PubMed    
     Abstract available
     
     

183. LEI X, Wang Y, Chen Y, Duan J, et al
     Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer Through Dual Targeting of Cancer Cells and Cancer Stem Cells: Evidence from In Vitro and In Vivo Models.
     Molecules. 2025;30:2377.
     PubMed    
     Abstract available
     
     

184. RENTERIA-FLORES FI, Molina-Pineda A, Pina-Cruz R, Vizcarra-Ramos S, et al
     Transforming Properties of E6/E7 Oncogenes from Beta-2 HPV80 in Primary Human Fibroblasts.
     Int J Mol Sci. 2025;26:5347.
     PubMed    
     Abstract available
     
     

185. SUSTOVA P, Engesaeter B, Ovestad IT, Gudlaugsson EG, et al
     The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2-3: A Prospective Population-Based Cohort Study.
     Int J Mol Sci. 2025;26:5205.
     PubMed    
     Abstract available
     
     

186. BOONYARAT C, Sakurai H, Hayakawa Y, Chaiwiwatrakul S, et al
     Dihydrocapsaicin Enhances Tumor Necrosis Factor-alpha-Induced Apoptosis and G1 Cell Cycle Arrest in Human Cervical Cancer Cells Through TAK1-Mediated NF-kappaB and EGFR Pathways.
     Int J Mol Sci. 2025;26:5011.
     PubMed    
     Abstract available
     
     

187. DA SILVA PHCM, Molino GOG, Dias MMF, Pereira AGA, et al
     Adjuvant Radiotherapy for Intermediate-Risk Early-Stage Cervical Cancer Post Radical Hysterectomy: A Systematic Review and Meta-Analysis.
     J Clin Med. 2025;14:4002.
     PubMed    
     Abstract available
     
     

188. PIORECKA A, Marcinkowska W, Gagorowski F, Gasior M, et al
     Cervical Dysplasia and Cervical Cancer During Pregnancy: From Pathogenesis to Clinical Management.
     J Clin Med. 2025;14:3784.
     PubMed    
     Abstract available
     
     

189. VIDA B, Keszthelyi E, Toth Z, Loczi L, et al
     The Neutrophil-to-Lymphocyte Ratio (NLR) as a Potential Predictor in Conization Outcomes for Cervical Cancer.
     Cancers (Basel). 2025;17:1856.
     PubMed    
     Abstract available
     
     

190. NAJJARI-JAMAL D, Juarez M, Cordoba S, Celada F, et al
     The Crucial Role of Advanced Image-Guided Brachytherapy for Locally Advanced Cervical Cancer in the Era of Systemic Treatment Intensification.
     Cancers (Basel). 2025;17:1809.
     PubMed    
     Abstract available
     
     

191. HABBANI SF, Dowlatshahi S, Lichti N, Broman M, et al
     Protein Biomarkers Enable Sensitive and Specific Cervical Intraepithelial Neoplasia (CIN) II/III+ Detection: One Step Closer to Universal Cervical Cancer Screening.
     Cancers (Basel). 2025;17:1763.
     PubMed    
     Abstract available
     
     

192. TOGAMI S, Furuzono N, Fukuda M, Kobayashi H, et al
     Intraoperative Whole Sentinel Lymph Node Analysis Using the OSNA Assay in Early-Stage Cervical Cancer: A Comparative Study.
     Cancers (Basel). 2025;17:1753.
     PubMed    
     Abstract available
     
     

193. LEE YS, Kim CJ, Kim JH, Lee YS, et al
     Dynamics of Serum Inflammatory Markers Predict Survival After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
     Asia Pac J Clin Oncol. 2025 Jun 12:e14201. doi: 10.1111/ajco.14201.
     PubMed    
     Abstract available
     
     

194. JUNG DR, Choi Y, Jeong M, Singh V, et al
     Metagenomic insight into the vaginal microbiome in women infected with HPV 16 and 18.
     NPJ Biofilms Microbiomes. 2025;11:105.
     PubMed    
     Abstract available
     
     

195. KIM SW, Kang MJ, Kim YS, Hwang WY, et al
     Novel biomarker discovery-coupled plasma therapy with enhanced tumor penetration for non-surgical treatment of cervical cancer.
     J Control Release. 2025 Jun 10:113946. doi: 10.1016/j.jconrel.2025.113946.
     PubMed    
     Abstract available
     
     

196. EKSTEEN C, Riedemann J, van der Merwe FH, Botha MH, et al
     Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response.
     Semin Oncol. 2025;52:152352.
     PubMed    
     Abstract available
     
     

197. CHEN M, Ma J, Cui X, Dai Q, et al
     Advancing medical education in cervical cancer control with large language models for multiple-choice question generation.
     Med Teach. 2025 Jun 12:1-11. doi: 10.1080/0142159X.2025.2513419.
     PubMed    
     Abstract available
     
     

198. SUNDRIYAL D, Bahurupi Y, Rajaram S, Singh M, et al
     Perspective of females from a rural community in India toward the knowledge, screening, and treatment of breast and cervical cancer and preventive vaccination.
     Cancer Causes Control. 2025 Jun 12. doi: 10.1007/s10552-025-02018.
     PubMed    
     Abstract available
     
     

199. MENG Y, Cui L, Fang C, Yang F, et al
     Simplifying surgical criteria for early-stage cervical cancer: prognostic equivalence of total vs. radical hysterectomy in a retrospective SEER cohort analysis.
     Int J Surg. 2025 Jun 12. doi: 10.1097/JS9.0000000000002731.
     PubMed    
     Abstract available
     
     

200. YIN C, Li XB
     Unlocking early detection: How screening can save lives from cervical cancer.
     World J Clin Oncol. 2025;16:102456.
     PubMed    
     Abstract available
     
     

201. MIDDELDORP M, Brouwer JGM, Duijster JW, Knol MJ, et al
     The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands: a population-based linkage study.
     Lancet Reg Health Eur. 2025;54:101327.
     PubMed    
     Abstract available
     
     

202. KONG H, Geng J, Wang Q, Zhu J, et al
     Exploring the mediating roles of stigma and perceived social support between health literacy and health care decision-making barriers among patients with cervical cancer.
     Asia Pac J Oncol Nurs. 2025;12:100716.
     PubMed    
     Abstract available
     
     

203. LE NA, Patel S, Mutyala K, Issac A, et al
     Outpatient hybrid intracavitary-interstitial brachytherapy for cervical cancer with minimal sedation in a freestanding setting.
     Gynecol Oncol Rep. 2025;59:101767.
     PubMed    
     Abstract available
     
     

204. MAYADEV J, Vazquez Limon JC, Ramirez Godinez FJ, Leiva M, et al
     Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.
     Ann Oncol. 2025 Jun 2:S0923-7534(25)00738-0. doi: 10.1016/j.annonc.2025.
     PubMed    
     Abstract available
     
     

205. HUANG L, Liu L, Zhao K, Zhou D, et al
     Prognosis of locally advanced cervical cancer following neoadjuvant chemotherapy and radical surgery: A SEER database analysis.
     Curr Probl Surg. 2025;68:101794.
     PubMed    
     
     
     

206. ADEBAMOWO C, Rossi PG, Castle PE
     Challenges and Opportunities for Global Cervical Cancer Elimination: How Can We Build a Model for Other Cancers?
     Am Soc Clin Oncol Educ Book. 2025;45:e473702.
     PubMed    
     Abstract available
     
     

207. RANGEIRO R, Lopes A, Munsell MF, Changule D, et al
     Cervical Cancer Outcomes in Mozambique: Impact of an International Gynecologic Oncology Training Program.
     JCO Glob Oncol. 2025;11:e2500024.
     PubMed    
     Abstract available
     
     

208. ZHAN X, Jiang Y, Li Z, Hu X, et al
     Split DNA Tetrahedron-Mediated Spatiotemporal-Hierarchy CRISPR Cascade Integrated with Au@Pt Nanolabels and Artificial Intelligence for a Cervical Cancer MicroRNA Bioassay.
     ACS Nano. 2025 Jun 11. doi: 10.1021/acsnano.5c01376.
     PubMed    
     Abstract available
     
     

209. PALMER C, Skroumpelos A, Sabale U, Gountas I, et al
     Strategies to accelerate cervical cancer elimination in Greece: a modeling study.
     Front Oncol. 2025;15:1480942.
     PubMed    
     Abstract available
     
     

210. SINGH HV, Nakken E, Fauske L
     Bridging cultural and linguistic barriers: South Asian minority women's experiences of radiotherapy for cervical cancer in Norway.
     Tech Innov Patient Support Radiat Oncol. 2025;34:100315.
     PubMed    
     Abstract available
     
     

211. ABU EL KHEIR-MATARIA W, Chun S
     Climate change and women's cancer in the MENA region: assessing temperature-related health impacts.
     Front Public Health. 2025;13:1529706.
     PubMed    
     Abstract available
     
     

212. GALARRAGA G, Lopez-Gil JF
     Making human papillomavirus testing a public health priority in Ecuador.
     Front Public Health. 2025;13:1535580.
     PubMed    
     Abstract available
     
     

213. OLSSON SE, Shah S, Haase E, Pagidas K, et al
     Perceptions and Barriers to Human Papillomavirus Vaccination and Cervical Cancer Screenings: A Survey Study of Underserved Populations in North Texas.
     Public Health Chall. 2024;3:e70018.
     PubMed    
     Abstract available
     
     

214. HAIDER J, Mahmood H, Faheem M
     Acute toxicity profile and treatment response of image guided hybrid brachytherapy using Venezia applicators in locally advanced cervical cancer: a single-centre experience in Pakistan.
     Ecancermedicalscience. 2025;19:1883.
     PubMed    
     Abstract available
     
     

215. LUWEN G, Hameed H, Aslam B, Liyan Z, et al
     Understanding of cervical cancer, human papillomavirus (HPV) and HPV vaccine among women from Pakistan and Afghanistan.
     Ecancermedicalscience. 2025;19:1891.
     PubMed    
     Abstract available
     
     

216. GAO S, Song Y
     Clinical pathological and molecular features of 100 patients with gastric-type cervical adenocarcinoma.
     Diagn Pathol. 2025;20:73.
     PubMed    
     Abstract available
     
     

217. YANG M, Ma Y, Cao Z, Zhan H, et al
     HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-kappaB Pathway in Cervical Cancer.
     Biochem Genet. 2025 Jun 10. doi: 10.1007/s10528-025-11144.
     PubMed    
     Abstract available
     
     

218. FENG YS, Chen SM, Wang MY, Yin J, et al
     [The positive rate of high-risk human papillomavirus DNA and neutralizing antibodies and the association with cervical intraepithelial neoplasia in rural women of Shanxi Province].
     Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:803-809.
     PubMed    
     Abstract available
     
     

219. YANG N, Xia T, Huang Y
     LncRNA TTC28-AS1 promotes the progression of cervical cancer by targeting miR-377-3p.
     J Obstet Gynaecol Res. 2025;51:e16331.
     PubMed    
     Abstract available
     
     

220. AL-MARZOUQI Z, Al-Mamari H
     Omani Women's Experiences of Cervical Cancer Screening.
     Nurs Womens Health. 2025 Jun 7:S1751-4851(25)00112.
     PubMed    
     Abstract available
     
     

221. SEMPRINI J, Devine J, Reimer R
     Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022.
     JNCI Cancer Spectr. 2025 Jun 10:pkaf059. doi: 10.1093.
     PubMed    
     Abstract available
     
     

222. SHI Y, Liu W, Zhu M, Xu J, et al
     Vaginal and cervical tumors in children and adolescents: a SEER population-based study.
     Pediatr Surg Int. 2025;41:161.
     PubMed    
     Abstract available
     
     

223. WANG J, Salomonsson S, Sonmez D, Nordqvist Kleppe S, et al
     Mental disorders and socioeconomic outcomes in women with cervical cancer, their children and co-parents.
     J Natl Cancer Inst. 2025 Jun 10:djaf129. doi: 10.1093.
     PubMed    
     Abstract available
     
     

224. MENG S, Li X, Zhang J, Cheng X, et al
     Development and Validation of an Anoikis-Related Gene Signature for Prognostic Prediction in Cervical Cancer.
     Int J Gen Med. 2025;18:2861-2879.
     PubMed    
     Abstract available
     
     

225. FULAWKA L, Dawiec B, Homola W, Halon A, et al
     Case Report: Osteoclastic giant cell-rich cervical squamous cell carcinoma-the first reported case of a clinically silent early-detected keratinizing subtype with a detailed literature comparison.
     Pathol Oncol Res. 2025;31:1612076.
     PubMed    
     Abstract available
     
     

226. JI M, Huang Z, Yan H, Ren J, et al
     HPV vaccination coverage, hesitancy, and barriers: Insights from a serial cross-sectional study in Shanghai, China (2019-2024).
     Hum Vaccin Immunother. 2025;21:2513707.
     PubMed    
     Abstract available
     
     

227. ADAMS ED
     Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy: SHAPE Trial Comparing Simple Versus Radical Hysterectomy.
     J Obstet Gynecol Neonatal Nurs. 2025 Jun 6:S0884-2175(25)00189.
     PubMed    
     Abstract available
     
     

228. WANG S, Ma Z, Dong J, Zhang N, et al
     Development of a nomogram for predicting positive margins after cold knife conization in patients with high-grade squamous intraepithelial lesions.
     Medicine (Baltimore). 2025;104:e42759.
     PubMed    
     Abstract available
     
     

229. NELSON HD, Cantor AG, Pappas M, Blackie K, et al
     Patient Navigation Services for Breast and Cervical Cancer Screening and Follow-Up: A Meta-Analysis.
     JAMA Intern Med. 2025 Jun 9:e251590. doi: 10.1001/jamainternmed.2025.1590.
     PubMed    
     Abstract available
     
     

230. JIN D, Wang N, Xue Y, Yang Y, et al
     Pan-cancer analysis of ARNT2 and its oncogenic role in cervical cancer.
     J Gynecol Oncol. 2025 May 26. doi: 10.3802/jgo.2025.
     PubMed    
     Abstract available
     
     

231. JIN W, Li B, Zhang L, Sun C, et al
     Mechanisms Underlying the Therapeutic Effects of Brucea javanica in Cervical Cancer Treatment Based on Network Pharmacology and Molecular Docking.
     Int J Genomics. 2025;2025:9956789.
     PubMed    
     Abstract available
     
     

232. LIU Y, Liu Y, Wang Y, Wang Q, et al
     Correction: LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis.
     Oncol Res. 2025;33:1505.
     PubMed    
     Abstract available
     
     

233. MLAWA OM, Ngaile JE, Chaurasia PP, Amasi AI, et al
     Assessment of rectal dose with thermoluminescent in vivo dosimetry in high-dose-rate cobalt-60 intracavitary brachytherapy for cervical cancer: A two-arm cohort study using orthogonal images planning.
     J Contemp Brachytherapy. 2025;17:133-141.
     PubMed    
     Abstract available
     
     

234. HARPER DM, Navarro-Alonso JA, Bosch FX, Paavonen J, et al
     Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.
     Hum Vaccin Immunother. 2025;21:2497608.
     PubMed    
     Abstract available
     
     

235. FU X, Xia Y, Zhou W, Lu Y, et al
     Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysis.
     Expert Rev Vaccines. 2025;24:524-534.
     PubMed    
     Abstract available
     
     

236. SOLLIE B, Berkhof J, Bogaards JA
     Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands.
     BMC Med. 2025;23:339.
     PubMed    
     Abstract available
     
     

237. ZHANG Y, Fan Z, Wang J, Guan B, et al
     HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications.
     BMC Womens Health. 2025;25:285.
     PubMed    
     Abstract available
     
     

238. TROISI G, Gafer N, Alsawahli H, Elmusharaf K, et al
     Harnessing primary healthcare to reduce the burden of cervical cancer in the Eastern Mediterranean Region.
     BMJ Glob Health. 2025;10:e017622.
     PubMed    
     Abstract available
     
     

239. WANG SM, Rahman S, Salinas M, Castro J, et al
     Impact of educational video on cervical cancer knowledge in hispanic patients: A randomized trial.
     Patient Educ Couns. 2025;138:109202.
     PubMed    
     Abstract available
     
     

240. TANG XB, Zhang Y, Ma SS, Jiang L, et al
     The Role of Radiotherapy for Metastatic Cervical Cancer: A Real-World Study.
     Clin Oncol (R Coll Radiol). 2025;43:103867.
     PubMed    
     Abstract available
     
     

241. KHALIFA H, Ayaty M, Oreaba R, Emad R, et al
     Neoadjuvant chemoradiation and surgical excision versus definitive radiotherapy for locally advanced cervix uteri carcinoma: in terms of early and late complications and locoregional recurrence.
     J Egypt Natl Canc Inst. 2025;37:46.
     PubMed    
     Abstract available
     
     

242. LIU B, Liu Y, He H, Chen W, et al
     The clinical practice and outcomes of minimally invasive surgery in primary malignant melanoma of the vagina and cervix patients: a retrospective cohort study.
     Orphanet J Rare Dis. 2025;20:286.
     PubMed    
     Abstract available
     
     

243. BANILA C, Ladoukakis E, Scibior-Bentkowska D, Santiago LR, et al
     A longitudinal pilot study in pre-menopausal women links cervicovaginal microbiome to CIN3 progression and recovery.
     Commun Biol. 2025;8:883.
     PubMed    
     Abstract available
     
     

244. PRATHER KA, Chowdhury SK, Puri H, Zacharias E, et al
     The association of childhood experiences of abuse on timely cervical cancer screening utilization among women in the United States.
     Prev Med. 2025;197:108326.
     PubMed    
     Abstract available
     
     

245. STENHOUSE K, McGeachy P, Spampinato S, Tanderup K, et al
     A simulated annealing-based Bayesian network structure optimization framework for late morbidity prediction with a large prospective dataset.
     Med Phys. 2025;52:5051-5063.
     PubMed    
     Abstract available
     
     

246. JING Q, Pu W, Guo P, Liao X, et al
     Sarcomatoid squamous cell carcinoma of the cervix: A case series and literature review.
     Ann Diagn Pathol. 2025;78:152501.
     PubMed    
     Abstract available
     
     

247. LIN KY, Lin IF, Wu PF, Tsai WC, et al
     Recommendations and guidance for human papillomavirus (HPV) vaccination for adults in Taiwan.
     J Microbiol Immunol Infect. 2025;58:383-396.
     PubMed    
     Abstract available
     
     

248. GALVIN AM, Akpan IN, Garg A, Cuccaro PM, et al
     HPV-related cancer prevention among people experiencing housing instability: A systematic review.
     Sex Transm Dis. 2025 Mar 14. doi: 10.1097/OLQ.0000000000002159.
     PubMed    
     Abstract available
     
     

249. YI X, Song Y, Zhang H, Cui H, et al
     A workflow to select local tolerance limits by combining statistical process control and error curve model.
     Med Phys. 2025;52:4815-4827.
     PubMed    
     Abstract available
     
     

250. WDOWIARZ K, Reinholz-Jaskolska M, Radowicka M, Wielgos M, et al
     Gynecological complications and treatment strategies in patients after hematopoietic stem cell transplantation.
     Ginekol Pol. 2025;96:399-404.
     PubMed    
     Abstract available
     
     

251. MENDOZA RP, Ramineni M, Doytcheva K, Gabutan EC, et al
     Molecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix.
     Int J Gynecol Pathol. 2025;44:323-330.
     PubMed    
     Abstract available
     
     

252. XU L, Li J, Ma J, Hasim A, et al
     Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis.
     Mol Oncol. 2025;19:1668-1686.
     PubMed    
     Abstract available
     
     

253. HE J, Wu Y, Su Y
     Nursing Care of Postoperative Supplementary Surgery for Patients with Positive or High-level CIN after Conization Using CINIII Cold Knife.
     Altern Ther Health Med. 2025;31:278-283.
     PubMed    
     Abstract available
     
     

254. ZHANG T, Gu F, He JY, Li W, et al
     Low-coverage whole-genome sequencing for differentiating cervical cancer from cervical intraepithelial neoplasia and benign diseases.
     Chromosome Res. 2025;33:12.
     PubMed    
     Abstract available
     
     

255. GUO W, Dai L, Qiu L
     T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.
     Front Immunol. 2025;16:1612032.
     PubMed    
     Abstract available
     
     

256. CRANE L, Jennings A, Fitzpatrick MB, Mukherjee M, et al
     Experiences and Preferences Reported with an At-Home Self-Collection Device Compared with In-Clinic Speculum-Based Cervical Cancer Screening in the United States.
     Womens Health Rep (New Rochelle). 2025;6:564-575.
     PubMed    
     Abstract available
     
     

257. LIU W, Fu Y, Jiang X, Tan J, et al
     Astragalus polysaccharide regulates the cervical cancer cell cycle and inhibits cisplatin resistance by blocking the Wnt/beta-catenin pathway through the PPARD/CDC20 axis.
     Cytotechnology. 2025;77:126.
     PubMed    
     Abstract available
     
     

258. JIANG J, Li L, Zhang C, Yang C, et al
     The application of liquid biopsy techniques in cervical cancer diagnosis, prediction and therapeutic surveillance.
     J Gynecol Oncol. 2025 Jun 5. doi: 10.3802/jgo.2025.
     PubMed    
     Abstract available
     
     

259. LI P, Chen J, Wang J, Liu T, et al
     Gap junction protein beta 5 interacts with Galphai3 to promote Akt activation and cervical cancer cell growth.
     Cell Death Dis. 2025;16:461.
     PubMed    
     Abstract available
     
     

260. TANG Q, Yang Y, Sun J
     EZH2 regulates tumor-associated macrophages by the KDM6A-mediated inflammatory response in HPV16-positive cervical cancer.
     Hum Cell. 2025;38:119.
     PubMed    
     Abstract available
     
     

261. ZHU C, Gong Z, Yin P, Huang J, et al
     The Oncologist, 2025, Vol, XX, Issue XX Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer.
     Oncologist. 2025;30:oyaf133.
     PubMed    
     Abstract available
     
     

262. 
     Retraction notice to "Knowledge and attitude toward cervical cancer screening among women aged 30-49 years attending selected health facilities in Ethiopia: using structural equation model" [Heliyon 10 (2024) e31596].
     Heliyon. 2025;11:e43406.
     PubMed    
     Abstract available
     
     

263. OBEAGU EI
     Modulation of Chronic Cytokine Dysregulation in Cervical Cancer: Potential Biomarkers and Therapeutic Targets.
     Cancer Manag Res. 2025;17:1113-1126.
     PubMed    
     Abstract available
     
     

264. ARAGAO RS, Santos CL, Impieri Souza A, Fassizoli da Fonte AL, et al
     Evaluation of chronic radiation proctitis in patients with cervical cancer treated with pelvic radiotherapy: a cross-sectional study.
     Rev Bras Ginecol Obstet. 2025;47:e-rbgo26.
     PubMed    
     Abstract available
     
     

265. MALLUM A, Tendwa MB, Saidu R, Swanson W, et al
     A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study.
     Front Oncol. 2025;15:1552346.
     PubMed    
     Abstract available
     
     

266. SHERIF RS, Kareem HM, El-Gebaly RH, Shehata MA, et al
     Comparative study of brachytherapy using ring and ovoid applicators in treatment of advanced cervical cancer.
     Int J Risk Saf Med. 2025 Jun 19:9246479251353380. doi: 10.1177/09246479251353380
     PubMed    
     Abstract available
     
     

267. SHANG L, Yan R, Wang H, Li Z, et al
     Hsa_circ_0101308 adjusted by N6-methyladenosine (m(6)A) impacts chemo-resistance in cervical cancer via sponging miR-224.
     Cancer Biomark. 2025;42:18758592251341157.
     PubMed    
     Abstract available
     
     

268. MAI YJ, Zhou ZH, Li QL, Yu JH, et al
     [Epidemic Characteristics and disease burden trend of cervical cancer in Guangxi Zhuang Autonomous Region, 2010-2017].
     Zhonghua Zhong Liu Za Zhi. 2025;47:491-497.
     PubMed    
     Abstract available
     
     

269. FU ZT, Jiang F, Lu ZL, Chu J, et al
     [Analysis of the trend and spatial aggregation of cervical cancer mortality in Shandong Province, 1970-2021].
     Zhonghua Zhong Liu Za Zhi. 2025;47:485-490.
     PubMed    
     Abstract available
     
     

270. DUO Y, Kang C, Zheng L, Wang J, et al
     circ-NOLC1 inhibits the development of cervical cancer by regulating miR-330-5p-PALM signaling axis.
     Hereditas. 2025;162:108.
     PubMed    
     Abstract available
     
     

271. YANG X, Qi S, Dai L, Ye Q, et al
     Trends in HPV-positive cervical cancer prevalence: a retrospective study from 2013 to 2020.
     Virol J. 2025;22:199.
     PubMed    
     Abstract available
     
     

272. XU J, Yang W, Liu L, Zhou S, et al
     Publication trends and hotspots for cervical cancer screening biomarker: a bibliometric analysis.
     Discov Oncol. 2025;16:1151.
     PubMed    
     Abstract available
     
     

273. ROLLER LA, Venkatesan AM, Nougaret S, Sadowski E, et al
     Cervical Cancer Reporting Lexicon: A Collaboration by the SAR Uterine and Ovarian Cancer DFP, ESUR Female Pelvic Imaging Working Group, and Asian Society of Abdominal Radiology.
     AJR Am J Roentgenol. 2025 Jun 18. doi: 10.2214/AJR.25.33087.
     PubMed    
     Abstract available
     
     

274. BEN DIOUF O, Gilbert A, Bernay B, Soumboundou M, et al
     Multi-proteomics investigation of the early response to X-rays and carbon ion irradiations of HeLa cells.
     Integr Biol (Camb). 2025;17:zyaf008.
     PubMed    
     Abstract available
     
     

275. ONCU HN, Ege G, Sucu ST, Ozturk N, et al
     The impact of human papillomavirus 16/18 positivity on cyberchondria levels in women undergoing colposcopy.
     Rev Assoc Med Bras (1992). 2025;71:e20241692.
     PubMed    
     Abstract available
     
     

276. SAHA I, Halder J, Kanti Rajwar T, Rai VK, et al
     A Novel Mucoadhesive Phytic Acid Grafted Chitosan Nanocarrier Encapsulated with Cisplatin for Site-Specific Cervical Cancer Therapy: In-Vitro and In-Vivo Assessments.
     J Drug Target. 2025 Jun 18:1-25. doi: 10.1080/1061186X.2025.2519599.
     PubMed    
     Abstract available
     
     

277. SINDHU KJ, Nalini V, Sandhya S, Karunagaran D, et al
     Exploring the role of circRNA-miRNA-mRNA interactions in cervical cancer progression: insights into HPV status and potential therapeutic approaches.
     J Appl Genet. 2025 Jun 18. doi: 10.1007/s13353-025-00982.
     PubMed    
     Abstract available
     
     

278. FLORIT A, Noortman WA, Bizzarri N, Pasciuto T, et al
     An exploratory assessment of early and delta PET radiomic features for outcome prediction in locally advanced cervical cancer.
     Eur J Nucl Med Mol Imaging. 2025 Jun 18. doi: 10.1007/s00259-025-07405.
     PubMed    
     Abstract available
     
     

279. SANCHEZ-MEZA LV, Bello-Rios C, Gomez-Gomez Y, Leyva-Vazquez MA, et al
     Therapies and nanotherapies for cervical cancer (Review).
     Biomed Rep. 2025;23:132.
     PubMed    
     Abstract available
     
     

280. GARLAND J, Moore KN, Walker JL, Benbrook DM, et al
     The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance.
     Transl Cancer Res. 2025;14:2539-2543.
     PubMed    
     
     
     

281. JIANG N, Xiong X, Chen X, Feng M, et al
     Machine learning and deep learning to improve overall survival prediction in cervical cancer patients.
     Transl Cancer Res. 2025;14:3057-3068.
     PubMed    
     Abstract available
     
     

282. SALTA S, Sequeira JP, Amorim-Fernandes B, Lobo J, et al
     Methylation-Specific Droplet Digital PCR: Testing a Novel Triage Tool for HrHPV-Positive Women in the Cervical Cancer Screening Program of Northern Portugal.
     MedComm (2020). 2025;6:e70203.
     PubMed    
     
     
     

283. DANG YP, Yuan XY, Tian R, Li DG, et al
     [Retracted] Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-kappaB-p53-caspase-3 pathway.
     Exp Ther Med. 2025;30:152.
     PubMed    
     Abstract available
     
     

284. PAN B, Huang H, Wan T, Huang Q, et al
     The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study.
     Front Immunol. 2025;16:1582299.
     PubMed    
     Abstract available
     
     

285. WALL JA, Nix-Parker T, Klein K, Bakitas MA, et al
     Cervical cancer patients' knowledge and experiences with palliative care - A qualitative study.
     Gynecol Oncol Rep. 2025;59:101774.
     PubMed    
     Abstract available
     
     

286. LIAN Y, Luo P
     Mortality of Three Major Gynecological Cancers in the European Region: An Age-Period-Cohort Analysis from 1992 to 2021 and Predictions in a 25?Year Period.
     Ann Glob Health. 2025;91:30.
     PubMed    
     Abstract available
     
     

287. WANG ST, Ma GF, Xiao CL, Shi TY, et al
     Concurrent cisplatin chemotherapy with intensity-modulated radiotherapy followed by consolidation chemotherapy in early-stage cervical cancer patients with high-risk factors after radical hysterectomy.
     J Obstet Gynaecol Res. 2025;51:e16346.
     PubMed    
     Abstract available
     
     

288. GRIFFITHS PM, Samra R, Lester G, Rawson-Harris P, et al
     Cervical cancer screening in women living with HIV: an audit of clinical care.
     AIDS. 2025 Jun 12. doi: 10.1097/QAD.0000000000004266.
     PubMed    
     Abstract available
     
     

289. BHATIA S, Siler M, Hollis-Hansen K, Schroder K, et al
     A Case Study of Food Insecurity Screening and Referral: Implementation Barriers, Facilitators, and Lessons from a Healthcare-Food Bank Partnership.
     J Prim Care Community Health. 2025;16:21501319251348144.
     PubMed    
     Abstract available
     
     

290. KUCUKYURT AK, Atakul N, Kolcu SA, Ozcan AJ, et al
     Is age a determinant in cervical cancer screening in women aged 18 to 29?: An observational study.
     Medicine (Baltimore). 2025;104:e42765.
     PubMed    
     Abstract available
     
     

291. DONG Y, Chang W, Lu B, Li Y, et al
     METTL5-mediated m(6)A modification of SLC7A11 promotes cervical cancer by inhibiting ferroptosis.
     Int J Biochem Cell Biol. 2025 Jun 15:106822. doi: 10.1016/j.biocel.2025.106822.
     PubMed    
     Abstract available
     
     

292. SCHEVENHOVEN VJC, Jansen EEL, de Kok IMCM
     Determining the optimal cervical cancer screening exit strategy in the Netherlands.
     Prev Med. 2025;197:108329.
     PubMed    
     Abstract available
     
     

293. SEMENOV VV, Kriachkova LV, Boata AE, Geanta MM, et al
     Trends in cervical cancer epidemiology and vaccination coverage in Ukraine.
     Wiad Lek. 2025;78:999-1005.
     PubMed    
     Abstract available
     
     

294. MUANGWONG P, Tharavichitkul E, Thiennimitr P, Chitapanarux I, et al
     Impact of Saccharomyces boulardii on acute gastrointestinal toxicities in patients undergoing pelvic radiotherapy for gynecologic cancers: a randomized controlled trial.
     Support Care Cancer. 2025;33:590.
     PubMed    
     Abstract available
     
     

295. HUDSON SM, Hudson C
     Is GP practice bowel, breast and cervical cancer screening coverage correlated with GP practice list inflation?
     J Med Screen. 2025 Jun 17:9691413251347408. doi: 10.1177/09691413251347408.
     PubMed    
     Abstract available
     
     

296. LU JL, Zheng Y, Shi H, Yu J, et al
     A comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions.
     Lasers Med Sci. 2025;40:284.
     PubMed    
     Abstract available
     
     

297. SHE L, Li Y, Wang H, Zhang J, et al
     Imaging-Based AI for Predicting Lymphovascular Space Invasion in Cervical Cancer: Systematic Review and Meta-Analysis.
     J Med Internet Res. 2025;27:e71091.
     PubMed    
     Abstract available
     
     

298. TOGAMI S, Furuzono N, Mizuno M, Kobayashi H, et al
     Comparison of Surgical and Oncological Outcomes between Laparoscopic and Open Surgeries in Patients with Stage IA1 Cervical Cancer.
     Gynecol Minim Invasive Ther. 2025;14:152-156.
     PubMed    
     Abstract available
     
     

299. YE H, Song L, Li Q, Shen C, et al
     Organoid technology in cervical cancer research.
     Am J Cancer Res. 2025;15:1988-2003.
     PubMed    
     Abstract available
     
     

300. MOTOHARA T, Nishimura A, Yamaguchi M, Katabuchi H, et al
     Survival Impact of Neoadjuvant Chemotherapy With Bevacizumab Followed by Radical Hysterectomy for Locally Advanced Cervical Cancer With Lymph Node Metastasis: Insights From a Single-Institution Experience.
     Cureus. 2025;17:e86032.
     PubMed    
     Abstract available
     
     

301. OSWALD S, Mureithi E, Tsanou B, Chapwanya M, et al
     MCMC-Driven mathematical modeling of the impact of HPV vaccine uptake in reducing cervical cancer.
     Sci Afr. 2025;28:None.
     PubMed    
     Abstract available
     
     

302. ZHONG S, Guo Q, Chen X, Luo X, et al
     Erratum: The inhibition of YTHDF3/m(6)A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer: Erratum.
     Int J Biol Sci. 2025;21:3825-3826.
     PubMed    
     Abstract available
     
     

303. ALSHEHRI MA, Alahdal H, Aloqbi AA, Shakoori AM, et al
     Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer.
     Front Oncol. 2025;15:1598883.
     PubMed    
     Abstract available
     
     

304. BIERRENBACH AL, Parellada CI, Rocha Sarmento TT, Barbour Oliveira JC, et al
     Impact of HPV vaccination on the hospitalizations for anogenital warts and high-grade cervical intraepithelial neoplasia in Brazil: A national analysis.
     Hum Vaccin Immunother. 2025;21:2514949.
     PubMed    
     Abstract available
     
     

305. KANEKO Y, Kabu K, Anazawa Y
     [Pharmacological characteristics of tisotumab vedotin (recombinant) (TIVDAK((R)) 40 ?mg Intravenous Solution) and clinical study results in recurrent or metastatic cervical cancer].
     Nihon Yakurigaku Zasshi. 2025 Jun 13. doi: 10.1254/fpj.24110.
     PubMed    
     Abstract available
     
     

306. HUANG T, Cao R, Gao C, Luo J, et al
     Construction and validation of a chemokine-related gene signature associated with prognosis, clinical significance, and immune microenvironment characteristics in cervical cancer.
     Discov Oncol. 2025;16:1114.
     PubMed    
     Abstract available
     
     

307. PEI K, Li D, Xi M
     ASO Visual Abstract: Simple Hysterectomy as a Viable Alternative to Radical Hysterectomy for Early Stage Cervical Cancer-A Population-Based Cohort Study.
     Ann Surg Oncol. 2025 Jun 14. doi: 10.1245/s10434-025-17689.
     PubMed    
     
     
     

308. GOMATHI M, Baby PN, Saranya K, Chinnathambi A, et al
     Unveiling the potential of lichen compounds hyaluronic acid conjugates for cervical cancer treatment: a comprehensive in silico analysis.
     J Biomol Struct Dyn. 2025 Jun 14:1-15. doi: 10.1080/07391102.2025.2516134.
     PubMed    
     Abstract available
     
     

309. WUBULI R, Ainiwaer Z, Niyazi M, Han L, et al
     DNA hypomethylation modification promotes BST2 expression in cervical cancer by facilitating STAT1 binding to the promoter of BST2.
     Infect Agent Cancer. 2025;20:36.
     PubMed    
     Abstract available
     
     

310. ZHANG Y, Ji L, Yang S
     Mendelian randomization analysis of immune cell characteristics and genetic variants in cervical cancer risk: a genome-wide association study.
     Discov Oncol. 2025;16:1093.
     PubMed    
     Abstract available
     
     

311. DING J, Hu H, Zhu Y, Xu X, et al
     Inhibiting CMTM4 reverses the immunosuppressive function of myeloid-derived suppressor cells and augments immunotherapy response in cervical cancer.
     J Immunother Cancer. 2025;13:e011776.
     PubMed    
     Abstract available
     
     

312. LIU Y, Ma P, Liu D, Liu Y, et al
     Gram-negative Intratumoral Bacteria Mediate Lymph Node Metastasis through LPS-TLR4/MAPK Signaling Pathway in Cervical Cancer.
     J Infect. 2025 Jun 11:106532. doi: 10.1016/j.jinf.2025.106532.
     PubMed    
     Abstract available
     
     

313. PENG S, Hou F, Yang X, Wang W, et al
     Therapeutic mRNA vaccines targeting human papillomavirus type 16 E7 protein demonstrate significant antitumor efficacy in murine models of HPV-associated tumors.
     Int J Pharm. 2025;680:125785.
     PubMed    
     Abstract available
     
     

314. XU J, Ji Q, Kong Q, Lv L, et al
     Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas.
     Cell Rep Med. 2025;6:102149.
     PubMed    
     Abstract available
     
     

315. PU X, Wang J, Gu Z, Ao H, et al
     Microbiome and metabolomic changes associated with HPV clearance in women undergoing local excisional treatment for cervical intraepithelial neoplasia.
     mSystems. 2025;10:e0051125.
     PubMed    
     Abstract available
     
     

316. CHEN X, Huang Y, Cai M, Tang S, et al
     Enhancing Parametrial Invasion Assessment in Cervical Squamous Cell Carcinoma: The Collaborative Impact of Diffusion Kurtosis Imaging & T2-Weighted Imaging, Exploring Tumor Core & 5-mm Peritumoral Tissue.
     Br J Radiol. 2025 May 8:tqaf100. doi: 10.1093.
     PubMed    
     Abstract available
     
     

317. ABI-RAAD R, Sun T, Krishnamurti U
     Human papillomavirus genotype distribution and its correlation with intraepithelial neoplasia, vaccination, and ethnicity.
     J Am Soc Cytopathol. 2025;14:273-278.
     PubMed    
     Abstract available
     
     

318. DE CASTRO CA, da Silva CF, Silva FL, Marchetti LO, et al
     Evaluating photodynamic therapy protocols for high-grade cervical neoplasia: A comparative study.
     Photodiagnosis Photodyn Ther. 2025;53:104603.
     PubMed    
     Abstract available
     
     

319. DE BONDT DD, Jansen EEL, Stogios C, McCurdy BR, et al
     Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study.
     Med Decis Making. 2025;45:545-556.
     PubMed    
     Abstract available
     
     

320. YERIM SA, Khazraji YC, Bekkali R, Bennai M, et al
     Evaluating the performance of the Xpert HPV assay in detecting HPV positive cases in Morocco.
     Tumour Virus Res. 2025;19:200318.
     PubMed    
     Abstract available
     
     

321. CALVIN DEVADASAN JD, Nithyanandhan K, Fletcher GJ, Kannangai R, et al
     HPV vaccines - A game changer for preventing HPV-related cancers.
     Indian J Med Microbiol. 2025;55:100847.
     PubMed    
     Abstract available
     
     

322. HAN Q, Wang T, Wu Z, Shi J, et al
     Efficacy and safety of photodynamic therapy mediatied by 5-aminolevulinic acid for the treatment of cervical intraepithelial neoplasia 3(CIN 3): A single-center, prospective, cohort study.
     Photodiagnosis Photodyn Ther. 2025;53:104573.
     PubMed    
     Abstract available
     
     

323. LIU Y, Li R, Li C, Wu R, et al
     Comparative analysis of photodynamic therapy and conization for cervical high-grade squamous intraepithelial lesion: A systematic review and meta-analysis.
     Photodiagnosis Photodyn Ther. 2025;53:104544.
     PubMed    
     Abstract available
     
     

324. DICK S, Heideman DAM, Berkhof J, Steenbergen RDM, et al
     Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A review.
     Tumour Virus Res. 2025;19:200308.
     PubMed    
     Abstract available
     
     

325. GHIANI L, Chiocca S
     The oncogenic role of the NSD histone methyltransferases in head and neck and cervical cancers.
     Tumour Virus Res. 2025;19:200301.
     PubMed    
     Abstract available
     
     

326. MO Y, Shu Y, Mo Y, Liu J, et al
     [CRISPR-Cas9-mediated CDC20 gene knockout inhibits cervical cancer cell proliferation, invasion and metastasis].
     Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1200-1211.
     PubMed    
     Abstract available
     
     

327. LI M, Yan J, Wei S, Zhao S, et al
     Macranthoside B Enhances Paclitaxel-induced Human Cervical Cancer Cell Apoptosis Through ROS-JNK Pathway.
     Anticancer Res. 2025;45:2859-2870.
     PubMed    
     Abstract available
     
     

328. LESSER LI, Datta E, Behal R
     Electronically-Delivered Push Notifications Improve Patient Adherence to Preventive Care.
     J Am Board Fam Med. 2025;38:239-246.
     PubMed    
     Abstract available
     
     

329. ATAC O, Peterson LE, Waters TM
     The Impact of COVID-19 on Cervical Cancer Screening in Primary Care.
     J Am Board Fam Med. 2025;38:209-222.
     PubMed    
     Abstract available
     
     

330. ULVANG ML, Kvile OF, Berg HF, Woie K, et al
     Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.
     Transl Oncol. 2025;59:102453.
     PubMed    
     Abstract available
     
     

331. XIA C, Jin X, Huang X
     Comment on predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery.
     Eur J Surg Oncol. 2025;51:110244.
     PubMed    
     
     
     

332. MTENGEZO J, Lee H, Dokiso Chirwa M
     Cervical Cancer Screening Among Women in Malawi: An Integrative Literature Review.
     Oncol Nurs Forum. 2025;52:265-280.
     PubMed    
     Abstract available
     
     

333. MAZINANI S, Aghazadeh M, Poortahmasebi V, Arafi V, et al
     Cervical cancer pathology and vaginal and gut microbiota: conception of the association.
     Lett Appl Microbiol. 2025 Jun 18:ovaf088. doi: 10.1093.
     PubMed    
     Abstract available
     
     

334. ROSE SB, McBain L, Garrett SM, Bell R, et al
     'I felt so empowered, respected and shame free.' Let's test for HPV participants' experience of HPV primary screening.
     J Prim Health Care. 2025;17:134-145.
     PubMed    
     Abstract available
     
     

335. ROSE SB, McBain L, Bell R, Innes C, et al
     Experience of HPV primary screening: a cross-sectional survey of 'Let's test for HPV' study participants in Aotearoa New Zealand.
     J Prim Health Care. 2025;17:123-133.
     PubMed    
     Abstract available
     
     

336. VALENTE-NINO GW, Jimenez-Wences H, Romero-Lopez MJ, Alarcon-Millan J, et al
     SLC7A1, SGK1 and HMGB2 are overexpressed in cervical cancer tissues and the miR?23b?3p/HMGB2 axis regulates cell migration and invasion.
     Mol Med Rep. 2025;32:235.
     PubMed    
     Abstract available
     
     

337. SHIMOMURA Y, Kaneda M, Enomoto N, Yoshida K, et al
     Transvaginal Needle Biopsy for the Diagnosis of Radiation-Induced Angiosarcoma in Cervical Cancer: Utility and Role of Next-Generation Sequencing.
     Cureus. 2025;17:e84869.
     PubMed    
     Abstract available
     
     

338. WU S, Li M, Ren X
     Construction and validation of a prediction model for postoperative recurrence risk of cervical high-risk lesions using nomogram analysis.
     Afr J Reprod Health. 2025;29:94-107.
     PubMed    
     Abstract available
     
     

339. MOHAN W, Maharaj RG, Khan R, David S, et al
     Prevalence and factors associated with uptake of cervical cancer screening at primary care facilities in Trinidad: a cross-sectional study.
     BMJ Public Health. 2025;3:e001297.
     PubMed    
     Abstract available
     
     

340. ZHANG Y, Liu JB, Liu MJ, Liu J, et al
     Risk factors for depression in patients in perimenopause with cervical cancer.
     World J Psychiatry. 2025;15:105568.
     PubMed    
     Abstract available
     
     

341. WANG M, Wang Z, Zou X, Yang D, et al
     Diagnostic and prognostic values of serum insulin-like growth factor binding protein 4 expression in cervical cancer.
     J Obstet Gynaecol Res. 2025;51:e16313.
     PubMed    
     Abstract available
     
     

342. YASAR S, Kadioglu A, Akyildiz A, Sever N, et al
     "Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
     Medicina (Kaunas). 2025;61:1100.
     PubMed    
     Abstract available
     
     

343. PERNIOLA G, D'Auge TG
     Editorial for Special Issue "Diagnosis and Treatment of Cervical Cancer".
     Medicina (Kaunas). 2025;61:1057.
     PubMed    
     Abstract available
     
     

344. MEYER M, Eksteen C, de Sousa C, Chellan N, et al
     Personalised Medicine in Cervical Cancer: Evaluating Therapy Resistance Through Multi-Model Approaches.
     Cancer Med. 2025;14:e70995.
     PubMed    
     Abstract available
     
     

345. REICH O, Regauer S
     HPV infection of endocervical reserve cells is underestimated in the natural history of cervical cancer.
     Am J Obstet Gynecol. 2025 Jun 24:S0002-9378(25)00416.
     PubMed    
     
     
     

346. NDEBIA EJ, Kamsu-Tchuente G
     HIV prevalence and its association with cervical cancer risk in southern Africa: a systematic review and meta-analysis.
     AIDS Rev. 2025 Jun 26. doi: 10.24875/AIDSRev.25000003.
     PubMed    
     Abstract available
     
     

347. ZHU Y, Wang H, Zhang B, Ding H, et al
     Promoting HPV vaccination among adolescent girls in low-resource areas of China: A multi-centered qualitative study.
     Hum Vaccin Immunother. 2025;21:2521940.
     PubMed    
     Abstract available
     
     

348. BOVELL AAN, Ncayiyana J, Ginindza TG
     Investigating Drug Treatment Costs and Patient Characteristics of Female Breast, Cervical, Colorectal, and Prostate Cancers in Antigua and Barbuda: A Retrospective Data Study (2017-2021).
     Int J Environ Res Public Health. 2025;22:930.
     PubMed    
     Abstract available
     
     

349. SONG H, Shin M, Seo M, Kim YW, et al
     Ischemic Heart Disease, Hematological Malignancies, and Infectious Diseases as Risk Factors for Cervical Cancer: A Study Based on Korean National Health Insurance Data.
     J Clin Med. 2025;14:4282.
     PubMed    
     Abstract available
     
     

350. APOORVA, Handa V, Batra S, Arora V, et al
     UNet with Attention Networks: A Novel Deep Learning Approach for DNA Methylation Prediction in HeLa Cells.
     Genes (Basel). 2025;16:655.
     PubMed    
     Abstract available
     
     

351. ALEEZADA ZN, Patel I, Yusuf N
     Understanding HPV-Induced Cancers and Investigating the Barriers Faced by Low- and Middle-Income Countries in Prevention and Treatment.
     Int J Mol Sci. 2025;26:5581.
     PubMed    
     Abstract available
     
     

352. RAY A
     Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis.
     Int J Mol Sci. 2025;26:5549.
     PubMed    
     Abstract available
     
     

353. VAZQUEZ B, Rojas-Garcia M, Rodriguez-Esquivel JI, Marquez-Acosta J, et al
     Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping Review.
     Diagnostics (Basel). 2025;15:1543.
     PubMed    
     Abstract available
     
     

354. PEREZ-PLASENCIA C, Orbe-Orihuela YC, Mendez-Herrera A, Deas J, et al
     Regulatory Genetic Networks by microRNAs: Exploring Genomic Signatures in Cervical Cancer.
     Biomedicines. 2025;13:1457.
     PubMed    
     Abstract available
     
     

355. HU T, Wu H, Cheng X, Gao H, et al
     Integrative Analysis of Neutrophil-Associated Genes Reveals Prognostic Significance and Immune Microenvironment Modulation in Cervical Cancer.
     Biomedicines. 2025;13:1348.
     PubMed    
     Abstract available
     
     

356. CHINTALA S, Dankoski MA, Maina TK, Oduor CI, et al
     Reduction of NFX1-123 and HPV 16 E6 and E7 Decreased Telomerase and CENP-F in Cervical Cancer Cell Lines.
     Cancers (Basel). 2025;17:2044.
     PubMed    
     Abstract available
     
     

357. OLTHOF EP, Wenzel HHB, van der Velden J, Stalpers LJA, et al
     Adjuvant Chemoradiotherapy or Radiotherapy Alone for Early Squamous Cervical Cancer with a Single Surgical-Pathological High-Risk Factor.
     Cancers (Basel). 2025;17:2041.
     PubMed    
     Abstract available
     
     

358. JUNG L, Klamminger GG, Nigdelis MP, Eltze E, et al
     Impact of HPV Testing Based on the 2020 Update of the German Cervical Cancer Screening Program-Data from a Retrospective Monocentric Study.
     Cancers (Basel). 2025;17:2024.
     PubMed    
     Abstract available
     
     

359. DAY S, Arendse KD, Scott SE, Moyo M, et al
     Challenges and facilitators in pathways to cancer diagnosis in Southern Africa: a qualitative study.
     BMJ Open. 2025;15:e099296.
     PubMed    
     Abstract available
     
     

360. THOMAS-PURCELL K, Sealy DA, Purcell D, Richards C, et al
     "That's our culture...": Understanding Cervical Cancer Stigma Through Caribbean Voices.
     J Cancer Policy. 2025 Jun 23:100609. doi: 10.1016/j.jcpo.2025.100609.
     PubMed    
     Abstract available
     
     

361. CRUIKSHANK ME, Hammer A
     Updating the basic biology of HPV infection in the early natural history of cervical cancer.
     Am J Obstet Gynecol. 2025 Jun 23:S0002-9378(25)00417.
     PubMed    
     
     
     

362. XIA L, Zhang K, Tang Y, Zhang G, et al
     Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study.
     J Clin Oncol. 2025 Jun 25:JCO2402495. doi: 10.1200/JCO-24-02495.
     PubMed    
     Abstract available
     
     

363. WIN TZK, Simms K, Thinn MM, Tin KN, et al
     A Review of Human Papillomavirus Prevalence and Cervical Cancer in Myanmar.
     J Epidemiol Glob Health. 2025;15:89.
     PubMed    
     Abstract available
     
     

364. JEDRYKA MA, Czekanski A, Kryszpin M, Poprawski T, et al
     Diagnostic Value of Superparamagnetic Iron Oxide Nanoparticles as a Tracer for Sentinel Lymph Node Mapping in Early-Stage Cervical Cancer: The Preliminary Clinical Experience.
     J Funct Biomater. 2025;16:196.
     PubMed    
     Abstract available
     
     

365. LIU L, Lin J, Li A, Xie N, et al
     Tumor Invasion Distance Based on MRI Is a Novel Prognostic Indicator for I-IIIB Cervical Cancer Patients Treated with Radiotherapy.
     Curr Oncol. 2025;32:355.
     PubMed    
     Abstract available
     
     

366. PARISI S, Ferrantelli G, Santacaterina A, Russi EG, et al
     Design and Development of a Device (Sifilotto((R))) for Tumour Tracking in Cervical Cancer Patients Undergoing Robotic Arm LINAC Stereotactic Body Radiation Therapy Boost: Background to the STARBACS Study.
     Curr Oncol. 2025;32:354.
     PubMed    
     Abstract available
     
     

367. PETRE I, Negru SM, Buleu F, Moleriu RD, et al
     Evaluating the Cost-Effectiveness of Cervical Cancer Screening and Treatment in Western Romania.
     Curr Oncol. 2025;32:336.
     PubMed    
     Abstract available
     
     

368. VAHABI M, Kithulegoda N, Moosapoor M, Lofters A, et al
     Voices from the Margins: Barriers and Facilitators to HPV Self-Sampling Among Structurally Marginalized People with a Cervix in the Greater Toronto Area and Ontario.
     Curr Oncol. 2025;32:327.
     PubMed    
     Abstract available
     
     

369. UMEZAKI Y, Fukuda A, Kurihara M, Hashiguchi M, et al
     Evaluation of Cervical Cancer Screening in Japan: Challenges and Future Directions for Negative Intraepithelial Lesion or Malignancy/High-Risk Human Papillomavirus Positive Case Management.
     Curr Oncol. 2025;32:295.
     PubMed    
     Abstract available
     
     

370. TSUBOYAMA T
     Toward Global Standardization in Imaging Terminology for Cervical Cancer.
     AJR Am J Roentgenol. 2025 Jun 25. doi: 10.2214/AJR.25.33419.
     PubMed    
     
     
     

371. ODUWOYE AO, Olabisi EO, Ojo EF, Dosumu TO, et al
     Acceptance and barriers to cervical cancer screening among mothers in a state-capital city: a descriptive cross-sectional study.
     Ecancermedicalscience. 2025;19:1916.
     PubMed    
     Abstract available
     
     

372. ZHANG Y, Pan H, Zhao X, Yi H, et al
     The Impact of HPV/HBV Coinfection on Cervical Cancer Risk: Potential Mediating Role of Ki67.
     J Med Virol. 2025;97:e70454.
     PubMed    
     Abstract available
     
     

373. AO M, Zhao A, Wu Y, Zhang H, et al
     Predictive factors of sentinel lymph node mapping failure in cervical cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2025;51:110230.
     PubMed    
     Abstract available
     
     

374. STUEBS FA, Beckmann MW, Poschke P, Heindl F, et al
     The Epidemiology of Cervical Cancer in Germany: A Registry-Based Analysis of Incidence, Survival, and Tumor Characteristics (2003-2021).
     Dtsch Arztebl Int. 2025;.
     PubMed    
     Abstract available
     
     

375. HEYS D, Libermann E, Fontenot HB
     In-Clinic Self-swab for Human Papillomavirus Offers New Option for Cervical Cancer Screening.
     Nurs Womens Health. 2025 Jun 16:S1751-4851(25)00115.
     PubMed    
     Abstract available
     
     

376. SHAYKEVICH A, Wojtowycz M
     Factors Associated with Cervical Cancer Screening for Women in New York State: Analyzing the 2022 NYS BRFSS.
     J Womens Health (Larchmt). 2025 Jun 24. doi: 10.1089/jwh.2025.0027.
     PubMed    
     Abstract available
     
     

377. XUE T, Zhou J, Wang B, Xiao L, et al
     Dosimetric comparison and prognostic analysis of helical tomotherapy vs. intensity-modulated radiation therapy in locally advanced cervical cancer.
     Oncol Lett. 2025;30:396.
     PubMed    
     Abstract available
     
     

378. ZHANG L, Li J, Shang Y, Yang Q, et al
     The diagnostic value of transvaginal sonoelastography for cervical cancer and cervical intraepithelial neoplasia: a systematic review and meta-analysis.
     Eur J Med Res. 2025;30:516.
     PubMed    
     Abstract available
     
     

379. XU D, Hou C, Chang J, Yang S, et al
     The effect of chloroquine on cervical cancer via the PI3K/AKT/MDM2 pathway.
     Discov Oncol. 2025;16:1179.
     PubMed    
     Abstract available
     
     

380. LI Y, Liu Y, Zhang Z, Ma J, et al
     Heterogeneity and influencing factors of cancer-related fatigue among patients with cervical cancer undergoing brachytherapy: A cross-sectional analysis.
     Asia Pac J Oncol Nurs. 2025;12:100714.
     PubMed    
     Abstract available
     
     

381. AL AYOUBI M, Abi Dargham SH, Hsayan FI, Sadek MH, et al
     Concomitant Gastric and Duodenal Metastases From Cervical Cancer Presenting With Upper Gastrointestinal Bleeding: A Rare Case.
     Cureus. 2025;17:e84620.
     PubMed    
     Abstract available
     
     

382. VATS S, Thakur S, Gupta M, Kumar V, et al
     A Retrospective Analysis Comparing the Dosimetric Parameters of Two Rectum-Sparing Techniques During Intracavitary Brachytherapy with Tandem-Ring Applicators for Cervical Cancer.
     Cancer Manag Res. 2025;17:1155-1168.
     PubMed    
     Abstract available
     
     

383. SONG H, Bai J, Wang Y, Xie J, et al
     Readout-segmented echo-planar imaging and conventional single-shot echo-planar imaging for determining cervical cancer image quality, lymphovascular space invasion, and lymph node metastasis status: a comparative study.
     Diagn Interv Radiol. 2025 Jun 23. doi: 10.4274/dir.2025.253283.
     PubMed    
     Abstract available
     
     

384. BALDOCK J, Shipley T, Paterson V
     The Design and Evaluation of Community-Informed Video Resources to Promote Safe and Inclusive Cervical Screening for South Australian LGBTIQ+ People With a Cervix.
     Health Promot J Austr. 2025;36:e70062.
     PubMed    
     Abstract available
     
     

385. KUDELA E, Berakova K, Rokos T, Kozubik E, et al
     The incidence of high-risk HPV infections in Slovakia at the start of the national organized screening for cervical cancer.
     Infect Agent Cancer. 2025;20:42.
     PubMed    
     Abstract available
     
     

386. KIRBY T
     England changes cervical cancer screening to every 5 years.
     Lancet Oncol. 2025 Jun 19:S1470-2045(25)00372.
     PubMed    
     
     
     

387. LI X, Han M
     Exosomal miRNA-188-3p derived from cancer-associated fibroblasts promotes ferroptosis in cervical cancer: Medical biothermal image analysis.
     SLAS Technol. 2025;33:100313.
     PubMed    
     Abstract available
     
     

388. ELISHAEV E, Harinath L, Ye Y, Matsko J, et al
     Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics System.
     Cancer Cytopathol. 2025;133:e70022.
     PubMed    
     Abstract available
     
     

389. ZEINALKHANI F, Kamali Hakim P, Aghasi M, Mahdavi Sabet F, et al
     Direct comparison of full protocol MRI and modified non-contrast MRI in staging of cervical cancer: a retrospective study.
     Abdom Radiol (NY). 2025 Jun 21. doi: 10.1007/s00261-025-05076.
     PubMed    
     Abstract available
     
     

390. DATTA M, Roy S, Das S, Taraphdar P, et al
     Awareness about Cervical Cancer and HPV Vaccine among Undergraduate College Students in Purba Barddhaman District, West Bengal: A Cross-Sectional Study.
     Asian Pac J Cancer Prev. 2025;26:2185-2195.
     PubMed    
     Abstract available
     
     

391. DUNJIC M, Turini S, Nejkovic L, Pikula A, et al
     Exploring the Potential of a Novel Oil Blend Therapy for Immunity Enhancement and Cervical Carcinoma Treatment.
     Asian Pac J Cancer Prev. 2025;26:2129-2136.
     PubMed    
     Abstract available
     
     

392. AL-MAHDAWI TT, Said AM, Hade IM, Yasin YS, et al
     Synergistic Cytotoxic Impact of Linagliptin - Ciprofloxacin Combination on Cervical Cancer Cell Line: Insights into Targeting Heat Shock Protein 60.
     Asian Pac J Cancer Prev. 2025;26:2117-2128.
     PubMed    
     Abstract available
     
     

393. MARDIATI N, Setiawan D, Hadi S, Wathan N, et al
     Protecting HPV Vaccination Acceptance Among Parents 5th and 6th Grade Elementary School in Indonesia.
     Asian Pac J Cancer Prev. 2025;26:2043-2048.
     PubMed    
     Abstract available
     
     

394. MASEKO TN, Dlamini X, Okello V, Nkambule R, et al
     Introduction of the HPV Vaccine among Young Girls to Reduce the Long-Term Risk of Cervical Cancer in Eswatini: Programmatic Decision and Roll Out.
     Asian Pac J Cancer Prev. 2025;26:1891-1897.
     PubMed    
     Abstract available
     
     

395. AGARWAL N, Mishra PK, Das S, Kumar A, et al
     Emerging Trends in cervical cancer Treatment: Transitioning from traditional to innovative delivery strategies.
     Int J Pharm. 2025;681:125878.
     PubMed    
     Abstract available
     
     

396. GU J, Chen C, Chen Y, Lv W, et al
     High-expression of BCL10 inhibits cell-mediated immunity within the tumor immune microenvironment.
     Front Immunol. 2025;16:1616321.
     PubMed    
     Abstract available
     
     

397. MENGISTIE BA, Yirsaw AN, Lakew G, Mekonnen GB, et al
     Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review.
     Front Public Health. 2025;13:1537250.
     PubMed    
     Abstract available
     
     

398. PALMER C, Matsuki T, Tobe K, You X, et al
     Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling study.
     J Med Econ. 2025;28:974-985.
     PubMed    
     Abstract available
     
     

399. XIAO S, Jia H, Guo Y, Ding X, et al
     Chemoprophylactic Effects of Epigallocatechin Gallate in Female Reproductive Cancers - A Review.
     J Diet Suppl. 2025;22:487-510.
     PubMed    
     Abstract available
     
     

400. STOLER M, Cullum R, Lucic D, Wright T Jr, et al
     Alinity m HR HPV Assay: United States Clinical Trial Design and High-Risk Human Papillomavirus Prevalence.
     J Low Genit Tract Dis. 2025;29:235-238.
     PubMed    
     Abstract available
     
     

401. BRAUNGART S, Davenport R
     Clear Cell Adenocarcinoma of the Uterine Cervix and Vagina in Children Without Exposure to Diethylstilbestrol.
     Pediatr Blood Cancer. 2025;72:e31786.
     PubMed    
     Abstract available
     
     

402. SCHNEEDE JB, Schneede P
     [Human papillomavirus (HPV) vaccination for cancer prevention].
     Urologie. 2025;64:664-668.
     PubMed    
     Abstract available
     
     

403. KOREN M, Zlajpah M, Poljak M, Komlos KF, et al
     Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis.
     Radiol Oncol. 2025;59:213-224.
     PubMed    
     Abstract available
     
     

404. UNG A, Riel J, Stowers P, Killeen J, et al
     Self-Collected Swabs for Primary HPV Screening in an Underscreened Population in Hawaii.
     J Low Genit Tract Dis. 2025;29:213-217.
     PubMed    
     Abstract available
     
     

405. ZHONG F, Zilla ML, Sun Y, Zeng X, et al
     The Significance of Extended HPV Genotyping for Detecting Endocervical Glandular Neoplasia for Atypical Glandular Cells.
     J Low Genit Tract Dis. 2025;29:223-228.
     PubMed    
     Abstract available
     
     

406. DESRAVINES N, Desjardins MR, Ferriss JS, Perrin J, et al
     Diagnosis to Excision: Estimates for Guideline-Concordant Treatment of High-Grade Cervical Intraepithelial Neoplasia.
     J Low Genit Tract Dis. 2025;29:243-250.
     PubMed    
     Abstract available
     
     

407. STOLNICU S, Rakislova N, Morato A, Allison D, et al
     Cervical Human Papillomavirus-Independent Squamous Cell Carcinoma: A Clinicopathological Review and Outcomes Analysis Compared With Human Papillomavirus-Associated Squamous Cell Carcinoma.
     Mod Pathol. 2025;38:100742.
     PubMed    
     Abstract available
     
     

408. SACO A, Carbonell S, Rakislova N, Matas I, et al
     Human Papillomavirus Infection and Cytological Atypia in Female Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
     Transplantation. 2025;109:e371-e378.
     PubMed    
     Abstract available
     
     

409. BAI Y, Reid J, Habbous S, Devlin RA, et al
     Interprofessional team-based primary care practice and preventive cancer screening: evidence from Family Health Teams in Ontario, Canada.
     Eur J Health Econ. 2025;26:855-868.
     PubMed    
     Abstract available
     
     

410. CLARKE MA, Befano B, Wentzensen N, Cheung LC, et al
     Associations of obesity with post-treatment risks of cervical precancer and cancer.
     Am J Obstet Gynecol. 2025;233:40.
     PubMed    
     Abstract available
     
     

411. ANSARI SA, Anshu
     Utility of p16INK4a Staining on Cell Blocks Prepared from Residual Liquid-Based Cervicovaginal Material.
     Acta Cytol. 2025;69:248-258.
     PubMed    
     Abstract available
     
     

412. FITZPATRICK P, Mooney T, Williams Y, Mohan CM, et al
     Lack of consensus in calculation of interval cancer rates for cervical cancer screening.
     Acta Obstet Gynecol Scand. 2025 Jun 16. doi: 10.1111/aogs.15172.
     PubMed    
     Abstract available
     
     

413. ZYLA RE, Dodington DW, Pakbaz S, Terzic T, et al
     Assessment of Interobserver Agreement Among Gynecologic Pathologists Between Three-Tier Versus Binary Pattern-based Classification Systems for HPV-associated Endocervical Adenocarcinoma.
     Am J Surg Pathol. 2024 Jul 17. doi: 10.1097/PAS.0000000000002289.
     PubMed    
     Abstract available
     
     

414. LEE SJ, Lee S, Nikas IP, Kim M, et al
     Clinical Significance of Different Histology and High-Risk HPV Types in Neuroendocrine Carcinomas of the Cervix.
     Am J Surg Pathol. 2025;49:701-710.
     PubMed    
     Abstract available
     
     

415. SU H, Jin X, Kong L, You Y, et al
     The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection.
     Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
     PubMed    
     Abstract available
     
     

416. JAMSHIDI M, Zare Karizi S, Baghizadeh H, Ezzatizadeh V, et al
     Determination of Prevalence and Genotype Distribution of High-Risk Human Papillomavirus in Varamin (Iran).
     Diagn Cytopathol. 2025;53:325-332.
     PubMed    
     Abstract available
     
     

417. MA J, Yang M, Huang G
     Human Papillomavirus Prevalence and Genotype Distribution Among Women With Cervical Cytological Abnormalities in Urumqi, Xinjiang, China.
     Diagn Cytopathol. 2025;53:315-324.
     PubMed    
     Abstract available
     
     

418. WANG H, Wang N
     Letter Re: Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
     Eur J Cancer. 2025 May 19:115515. doi: 10.1016/j.ejca.2025.115515.
     PubMed    
     
     
     

419. YADAV K, Bansal L, Prasad A
     A challenging case of non-puerperal uterine inversion masquerading as cervical mass in a young female.
     Eur J Obstet Gynecol Reprod Biol. 2025;311:114079.
     PubMed    
     Abstract available
     
     

420. LI J, Su S, Guo N, Zhang Z, et al
     Comparison of 5-ALA-PDT and LEEP for cervical squamous intraepithelial neoplasia: A systematic review and meta-analysis.
     Eur J Obstet Gynecol Reprod Biol. 2025;311:114026.
     PubMed    
     Abstract available
     
     

421. PAVONE M, Bizzarri N, Rychlik A, Persson J, et al
     In-transit metastatic lymph nodes in cervical cancer: A new staging and therapeutic concept.
     Eur J Obstet Gynecol Reprod Biol. 2025;312:114523.
     PubMed    
     Abstract available
     
     

422. ACOSTA U, Bebia V, Torne A, Carreras-Dieguez N, et al
     Topographic mapping of pelvic and aortic lymph node metastases in stage IIIC1r locally advanced cervical cancer: A retrospective study by the Spain-GOG group.
     Gynecol Oncol. 2025;198:49-54.
     PubMed    
     Abstract available
     
     

423. LEE JY, Boonyapipat S, Yuan G, Kim HS, et al
     AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer.
     Gynecol Oncol. 2025;198:25-32.
     PubMed    
     Abstract available
     
     

424. CHO WK, Park W, Kim SW, Lee KK, et al
     Postoperative hypofractionated intensity-modulated radiation therapy in cervical cancer: prospective phase 2 trial (POHIM_RT study).
     Gynecol Oncol. 2025;198:84-89.
     PubMed    
     Abstract available
     
     

425. ZHENG Y, Han J, Qu Y, Wang J, et al
     DNA methylation biomarkers for cervical cancer risk prediction in HIV-positive Nigerian women.
     Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35502.
     PubMed    
     Abstract available
     
     

426. RATH S
     Rising deaths due to cervical cancer among premenopausal women in Russia: An analysis of the global burden of disease-2021.
     Int J Gynaecol Obstet. 2025 Jun 18. doi: 10.1002/ijgo.70311.
     PubMed    
     
     
     

427. SEO JH, Yang TS, Kim HS, Cho WK, et al
     Prognostic impact of primary surgery in human papillomavirus-independent, advanced or metastatic endocervical adenocarcinoma: A bi-institutional retrospective study.
     Int J Gynaecol Obstet. 2025;170:250-258.
     PubMed    
     Abstract available
     
     

428. WU YC, Hsiao CH, Chen CH, Ko YL, et al
     Identification of vascular hotspots and analysis of micro-vessel flow velocity waveforms in high-grade squamous intraepithelial lesions of the cervix.
     Int J Gynaecol Obstet. 2025;170:200-208.
     PubMed    
     Abstract available
     
     

429. KACPERCZYK-BARTNIK J, El Hajj H, Toth I, Bizzarri N, et al
     Declaration on cervical cancer elimination: literature review and perspectives from early-career clinicians.
     Int J Gynecol Cancer. 2025;35:101902.
     PubMed    
     Abstract available
     
     

430. VILLEGAS SANCHEZ S, Ramirez Cantillo S, Hernandez Aramburo PM, Hernandez JM, et al
     Cervical cancer prevention in Colombian indigenous communities, a project by Acacia de Vida Foundation.
     Int J Gynecol Cancer. 2025 Jan 9:101623. doi: 10.1016/j.ijgc.2024.101623.
     PubMed    
     
     
     

431. LI J, Cai M, Xie C, Ding S, et al
     Survival outcomes and safety of nimotuzumab combined with radiotherapy +/- chemotherapy for locally advanced cervical cancer.
     Int J Gynecol Cancer. 2025;35:101930.
     PubMed    
     Abstract available
     
     

432. MEI X, Fobian SF, IJff M, Crezee J, et al
     High human papillomavirus viral load and local immune dysregulation are associated with poor clinical outcomes in patients with cervical cancer.
     Int J Gynecol Cancer. 2025;35:101924.
     PubMed    
     Abstract available
     
     

433. GUERRA RA, Tucker LY, Littell R, Kay AH, et al
     Long-term impact of surgical route and tumor size on risk of recurrence among early-stage cervical cancer patients in a managed care population.
     Int J Gynecol Cancer. 2025 May 10:101928. doi: 10.1016/j.ijgc.2025.101928.
     PubMed    
     Abstract available
     
     

434. KIM YJ, Yoo YJ, Jang JY, Kim YM, et al
     Follow-up strategies for patients with cervical cancer who achieved complete response after definitive chemoradiotherapy.
     Int J Gynecol Cancer. 2025 May 21:101933. doi: 10.1016/j.ijgc.2025.101933.
     PubMed    
     Abstract available
     
     

435. BOGANI G, Scambia G, Malzoni M, Casarin J, et al
     Erratum to 'Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertility-sparing approach: an analysis of the ETERNITY project' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101643].
     Int J Gynecol Cancer. 2025 Jun 5:101960. doi: 10.1016/j.ijgc.2025.101960.
     PubMed    
     
     
     

436. LINDEGAARD JC, Kirisits C, Schmid MP, Wulff CN, et al
     Impact of patient selection on real-world outcomes by using the EMBRACE-II treatment protocol in locally advanced cervical cancer.
     Int J Radiat Oncol Biol Phys. 2025 Jun 1:S0360-3016(25)00554.
     PubMed    
     Abstract available
     
     

437. MAYER CM, Scarinci IC, Huh WK
     Self-Collection for Human Papillomavirus Testing in Clinical Settings: An Opportunity to Reflect on the Disconnect Between Guidelines and Clinical Practice.
     Obstet Gynecol. 2025;146:34-38.
     PubMed    
     Abstract available
     
     

438. ZHANG C, Fan X, Yang J, Zhu P, et al
     EIF3B?METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer.
     Oncol Rep. 2025;54:103.
     PubMed    
     Abstract available
     
     

439. YE Y, Chen Y, Pan J, Li P, et al
     Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a step forward in precision oncology.
     BMC Cancer. 2025;25:963.
     PubMed    
     Abstract available
     
     

440. WANG Y, Lin AY, Wang DD, Lin PP, et al
     In situ phenotypic and karyotypic co-detection of aneuploid TCs and TECs in cytological specimens with abnormal cervical screening results.
     BMC Cancer. 2025;25:945.
     PubMed    
     Abstract available
     
     

441. SHI Y, Zhang L, Zhou Y, Liao X, et al
     A cross-sectional study of factors influencing sexual health among spouses of patients with cervical cancer.
     PLoS One. 2025;20:e0322141.
     PubMed    
     Abstract available
     
     

442. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
     Validity of the process and outcome specific measure in women with abnormal Papanicolaou screening test.
     PLoS One. 2025;20:e0325131.
     PubMed    
     Abstract available
     
     

443. ELBASYOUNI A, Kyama MC, El-Shemy HA, Mwitari PG, et al
     Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
     PLoS One. 2025;20:e0323680.
     PubMed    
     Abstract available
     
     

444. ENYEW EB, Kasaye MD, Kebede SD, Feyisa MS, et al
     Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis.
     PLoS One. 2025;20:e0325557.
     PubMed    
     Abstract available
     
     

445. ISLAM T, Khan MAS, Hawlader MDH, Meem NE, et al
     Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.
     PLoS One. 2025;20:e0325712.
     PubMed    
     Abstract available
     
     

446. SHAN Y, Abulikemu G, Liu L, Zhang Y, et al
     Risk factors associated with adverse outcomes after cervical conization in patients with cervical adenocarcinoma in situ.
     PLoS One. 2025;20:e0325748.
     PubMed    
     Abstract available
     
     

447. YANG Y, Lu Y, Li Y, Qin C, et al
     Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
     PLoS One. 2025;20:e0324260.
     PubMed    
     Abstract available
     
     

448. PATURY P, Russomano FB, Moreira MAM, Kappaun NRC, et al
     Associations between genetic HPV 16 diversity and cervical cancer prognosis.
     PLoS One. 2025;20:e0308895.
     PubMed    
     Abstract available
     
     

449. ARRIVILLAGA M, Torres MDM, Neira D, Garcia-Cifuentes JP, et al
     Patient acceptability of CITOBOT for cervical cancer screening: A mixed-method study.
     PLoS One. 2025;20:e0325805.
     PubMed    
     Abstract available
     
     

450. RANA T, Chan DNS, Law BMH, Choi KC, et al
     Determinants of cervical cancer screening utilisation among women in the least developed countries: A systematic review and meta-analysis.
     PLoS One. 2025;20:e0321627.
     PubMed    
     Abstract available
     
     

451. YAO Y, Chen Y, Yang A, Ye Y, et al
     MVT-Net: A novel cervical tumour segmentation using multi-view feature transfer learning.
     PLoS One. 2025;20:e0325424.
     PubMed    
     Abstract available
     
     

452. NDJENGUE BENGONE BC, Toniolo J, Filankembo Kava AC, Ngoungou EB, et al
     Psychological repercussions of breast or uterine cervical cancer disclosure to women in Gabon.
     PLoS One. 2025;20:e0326378.
     PubMed    
     Abstract available